{
  "doc_id": "33",
  "paragraphs": [
    {
      "paragraph_id": "1",
      "paragraph": "对于噻唑烷二酮类与α-葡萄糖苷酶抑制剂这两类口服降糖药物，目前国内糖尿病相关专业组织尚未发布专门的临床指南或共识，不过据悉，吡格列酮临床应用的专家共识很快将会发布，届时我们再进行介绍。本期我们先来看看胰岛素方面的中国指南/共识，下期再对近几年出现的几类新型降糖药进行总结，作为年底的“温故知新”。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "对于噻唑烷二酮类与α-葡萄糖苷酶抑制剂这两类口服降糖药物，目前国内糖尿病相关专业组织尚未发布专门的临床指南或共识，不过据悉，吡格列酮临床应用的专家共识很快将会发布，届时我们再进行介绍。",
          "start_idx": 0,
          "end_idx": 92,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "噻唑烷二酮类",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T1",
              "entity": "α-葡萄糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 19
            },
            {
              "entity_id": "T2",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 36
            },
            {
              "entity_id": "T3",
              "entity": "吡格列酮",
              "entity_type": "Drug",
              "start_idx": 62,
              "end_idx": 66
            },
            {
              "entity_id": "T5",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 22,
              "end_idx": 24
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R0",
              "head_entity_id": "T0",
              "tail_entity_id": "T2"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R1",
              "head_entity_id": "T5",
              "tail_entity_id": "T0"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R2",
              "head_entity_id": "T1",
              "tail_entity_id": "T2"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R3",
              "head_entity_id": "T5",
              "tail_entity_id": "T1"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R4",
              "head_entity_id": "T3",
              "tail_entity_id": "T2"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "本期我们先来看看胰岛素方面的中国指南/共识，下期再对近几年出现的几类新型降糖药进行总结，作为年底的“温故知新”。",
          "start_idx": 92,
          "end_idx": 148,
          "entities": [
            {
              "entity_id": "T4",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 11
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "2",
      "paragraph": "相比于其他降糖药物类别，胰岛素的成员最多，临床应用也各不相同，所以需要分开介绍。在这里我们将分为1型糖尿病与2型糖尿病、餐时/基础/预混胰岛素来看看相应的指南/共识是怎么说的。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "相比于其他降糖药物类别，胰岛素的成员最多，临床应用也各不相同，所以需要分开介绍。在这里我们将分为1型糖尿病与2型糖尿病、餐时/基础/预混胰岛素来看看相应的指南/共识是怎么说的。",
          "start_idx": 0,
          "end_idx": 88,
          "entities": [
            {
              "entity_id": "T6",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T7",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 53
            },
            {
              "entity_id": "T8",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 54,
              "end_idx": 59
            },
            {
              "entity_id": "T9",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 48,
              "end_idx": 50
            },
            {
              "entity_id": "T10",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 54,
              "end_idx": 56
            },
            {
              "entity_id": "T11",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 66,
              "end_idx": 71
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R5",
              "head_entity_id": "T9",
              "tail_entity_id": "T7"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R6",
              "head_entity_id": "T11",
              "tail_entity_id": "T7"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R7",
              "head_entity_id": "T10",
              "tail_entity_id": "T8"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R8",
              "head_entity_id": "T11",
              "tail_entity_id": "T8"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "3",
      "paragraph": "1型糖尿病：(《中国1型糖尿病胰岛素治疗指南》)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1型糖尿病：(《中国1型糖尿病胰岛素治疗指南》)",
          "start_idx": 0,
          "end_idx": 24,
          "entities": [
            {
              "entity_id": "T12",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T13",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 0,
              "end_idx": 2
            },
            {
              "entity_id": "T14",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T15",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 10,
              "end_idx": 12
            },
            {
              "entity_id": "T16",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R9",
              "head_entity_id": "T13",
              "tail_entity_id": "T12"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R10",
              "head_entity_id": "T15",
              "tail_entity_id": "T14"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R11",
              "head_entity_id": "T16",
              "tail_entity_id": "T14"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "4",
      "paragraph": "与发达国家的1型糖尿病人群相比，我国的1型糖尿病人群存在血糖达标率低、急慢性并发症发生率高、寿命短等明显不足。尽管国际上倡导“基础+餐时”胰岛素强化治疗方案，但该方案在我国1型糖尿病人群中的应用率很低，而以每日2次方案者居多。为此，中华医学会糖尿病学分会在2016年发布了《中国1型糖尿病胰岛素治疗指南》，以期规范我国的1型糖尿病胰岛素治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "与发达国家的1型糖尿病人群相比，我国的1型糖尿病人群存在血糖达标率低、急慢性并发症发生率高、寿命短等明显不足。尽管国际上倡导“基础+餐时”胰岛素强化治疗方案，但该方案在我国1型糖尿病人群中的应用率很低，而以每日2次方案者居多。为此，中华医学会糖尿病学分会在2016年发布了《中国1型糖尿病胰岛素治疗指南》，以期规范我国的1型糖尿病胰岛素治疗。",
          "start_idx": 0,
          "end_idx": 171,
          "entities": [
            {
              "entity_id": "T17",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T18",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 24
            },
            {
              "entity_id": "T19",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 6,
              "end_idx": 8
            },
            {
              "entity_id": "T20",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 19,
              "end_idx": 21
            },
            {
              "entity_id": "T21",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 30
            },
            {
              "entity_id": "T22",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 69,
              "end_idx": 72
            },
            {
              "entity_id": "T23",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 86,
              "end_idx": 91
            },
            {
              "entity_id": "T24",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 86,
              "end_idx": 88
            },
            {
              "entity_id": "T25",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 121,
              "end_idx": 124
            },
            {
              "entity_id": "T26",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 139,
              "end_idx": 144
            },
            {
              "entity_id": "T27",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 139,
              "end_idx": 141
            },
            {
              "entity_id": "T28",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 144,
              "end_idx": 147
            },
            {
              "entity_id": "T29",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 160,
              "end_idx": 165
            },
            {
              "entity_id": "T30",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 160,
              "end_idx": 162
            },
            {
              "entity_id": "T31",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 165,
              "end_idx": 168
            },
            {
              "entity_id": "T32",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 103,
              "end_idx": 107
            },
            {
              "entity_id": "T33",
              "entity": "达标率低",
              "entity_type": "Test_Value",
              "start_idx": 30,
              "end_idx": 34
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R12",
              "head_entity_id": "T19",
              "tail_entity_id": "T17"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R13",
              "head_entity_id": "T20",
              "tail_entity_id": "T18"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R14",
              "head_entity_id": "T21",
              "tail_entity_id": "T18"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R15",
              "head_entity_id": "T22",
              "tail_entity_id": "T23"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R16",
              "head_entity_id": "T32",
              "tail_entity_id": "T22"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R17",
              "head_entity_id": "T24",
              "tail_entity_id": "T23"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R18",
              "head_entity_id": "T27",
              "tail_entity_id": "T26"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R19",
              "head_entity_id": "T28",
              "tail_entity_id": "T26"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R20",
              "head_entity_id": "T30",
              "tail_entity_id": "T29"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R21",
              "head_entity_id": "T31",
              "tail_entity_id": "T29"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "5",
      "paragraph": "基本原则",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基本原则",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "6",
      "paragraph": "(1)1型糖尿病患者因自身胰岛素分泌绝对缺乏，完全或部分需要外源性胰岛素替代以维持体内糖代谢平衡和生存，基础加餐时胰岛素治疗是其首选的胰岛素治疗方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)1型糖尿病患者因自身胰岛素分泌绝对缺乏，完全或部分需要外源性胰岛素替代以维持体内糖代谢平衡和生存，基础加餐时胰岛素治疗是其首选的胰岛素治疗方案。",
          "start_idx": 0,
          "end_idx": 75,
          "entities": [
            {
              "entity_id": "T34",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 8
            },
            {
              "entity_id": "T35",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 3,
              "end_idx": 5
            },
            {
              "entity_id": "T36",
              "entity": "胰岛素分泌绝对缺乏",
              "entity_type": "Pathogenesis",
              "start_idx": 13,
              "end_idx": 22
            },
            {
              "entity_id": "T37",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 57,
              "end_idx": 60
            },
            {
              "entity_id": "T38",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 67,
              "end_idx": 70
            },
            {
              "entity_id": "T39",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 36
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R22",
              "head_entity_id": "T35",
              "tail_entity_id": "T34"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R23",
              "head_entity_id": "T36",
              "tail_entity_id": "T34"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R24",
              "head_entity_id": "T39",
              "tail_entity_id": "T34"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "7",
      "paragraph": "(2)应尽可能在避免低血糖的前提下使血糖达标，以降低远期并发症的发生风险，因此建议胰岛治疗方案必须个体化，制订方案时要兼顾胰岛功能血糖控制目标、血糖波动幅度、低血糖发生风险等。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)应尽可能在避免低血糖的前提下使血糖达标，以降低远期并发症的发生风险，因此建议胰岛治疗方案必须个体化，制订方案时要兼顾胰岛功能血糖控制目标、血糖波动幅度、低血糖发生风险等。",
          "start_idx": 0,
          "end_idx": 88,
          "entities": [
            {
              "entity_id": "T40",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 13
            },
            {
              "entity_id": "T41",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 20
            },
            {
              "entity_id": "T42",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 65,
              "end_idx": 67
            },
            {
              "entity_id": "T43",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 72,
              "end_idx": 74
            },
            {
              "entity_id": "T44",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 79,
              "end_idx": 82
            },
            {
              "entity_id": "T45",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 74,
              "end_idx": 76
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R25",
              "head_entity_id": "T41",
              "tail_entity_id": "T40"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "8",
      "paragraph": "(3)基础加餐时胰岛素替代治疗方法包括每日多次胰岛素注射和持续皮下胰岛素输注。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)基础加餐时胰岛素替代治疗方法包括每日多次胰岛素注射和持续皮下胰岛素输注。",
          "start_idx": 0,
          "end_idx": 39,
          "entities": [
            {
              "entity_id": "T46",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T47",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 26
            },
            {
              "entity_id": "T48",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 26,
              "end_idx": 28
            },
            {
              "entity_id": "T49",
              "entity": "皮下",
              "entity_type": "Method",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T50",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 36
            },
            {
              "entity_id": "T51",
              "entity": "每日多次",
              "entity_type": "Frequency",
              "start_idx": 19,
              "end_idx": 23
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R26",
              "head_entity_id": "T48",
              "tail_entity_id": "T47"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R27",
              "head_entity_id": "T51",
              "tail_entity_id": "T47"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R28",
              "head_entity_id": "T49",
              "tail_entity_id": "T50"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R29",
              "head_entity_id": "T51",
              "tail_entity_id": "T50"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "9",
      "paragraph": "临床用法",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床用法",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "10",
      "paragraph": "(1)每日多次胰岛素注射方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)每日多次胰岛素注射方案",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T52",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 10
            },
            {
              "entity_id": "T53",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 10,
              "end_idx": 12
            },
            {
              "entity_id": "T54",
              "entity": "每日多次",
              "entity_type": "Frequency",
              "start_idx": 3,
              "end_idx": 7
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R30",
              "head_entity_id": "T53",
              "tail_entity_id": "T52"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R31",
              "head_entity_id": "T54",
              "tail_entity_id": "T52"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "11",
      "paragraph": "基础胰岛素可通过中效胰岛素、长效胰岛素或长效胰岛素类似物给予，餐时胰岛素可通过短效胰岛或速效胰岛素类似物给予，详见表1。该指南指出与中效胰岛素相比，长效胰岛素类似物空腹血糖控制更好，夜间低血糖发生风险更低。具体用法：①体重在理想体重正负20%以内的成年患者，若无特殊情况每日胰岛素需要总量0.4~0.8单位/千克体重，每日总量也可以最小剂量12~18单位起始；儿童则需根据年龄、体重及血糖情况酌情处理。2每日胰岛素基础=全天胰岛素总量X(40%~60%)，长效胰岛素一般1次注射，中效胰岛素可每日1次或2次注射。③每日餐时量一般按餐时总量的35%、30%、35%分配在早中晚餐前。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基础胰岛素可通过中效胰岛素、长效胰岛素或长效胰岛素类似物给予，餐时胰岛素可通过短效胰岛或速效胰岛素类似物给予，详见表1。该指南指出与中效胰岛素相比，长效胰岛素类似物空腹血糖控制更好，夜间低血糖发生风险更低。具体用法：①体重在理想体重正负20%以内的成年患者，若无特殊情况每日胰岛素需要总量0.4~0.8单位/千克体重，每日总量也可以最小剂量12~18单位起始；儿童则需根据年龄、体重及血糖情况酌情处理。2每日胰岛素基础=全天胰岛素总量X(40%~60%)，长效胰岛素一般1次注射，中效胰岛素可每日1次或2次注射。",
          "start_idx": 0,
          "end_idx": 256,
          "entities": [
            {
              "entity_id": "T55",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 5
            },
            {
              "entity_id": "T56",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T57",
              "entity": "长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 19
            },
            {
              "entity_id": "T58",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 28
            },
            {
              "entity_id": "T59",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 36
            },
            {
              "entity_id": "T60",
              "entity": "短效胰岛",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 43
            },
            {
              "entity_id": "T61",
              "entity": "速效胰岛素类似物给予",
              "entity_type": "Drug",
              "start_idx": 44,
              "end_idx": 54
            },
            {
              "entity_id": "T62",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 66,
              "end_idx": 71
            },
            {
              "entity_id": "T63",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 74,
              "end_idx": 82
            },
            {
              "entity_id": "T64",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 82,
              "end_idx": 86
            },
            {
              "entity_id": "T65",
              "entity": "控制更好",
              "entity_type": "Level",
              "start_idx": 86,
              "end_idx": 90
            },
            {
              "entity_id": "T66",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 93,
              "end_idx": 96
            },
            {
              "entity_id": "T67",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 137,
              "end_idx": 140
            },
            {
              "entity_id": "T68",
              "entity": "0.4~0.8单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 144,
              "end_idx": 158
            },
            {
              "entity_id": "T69",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 192,
              "end_idx": 194
            },
            {
              "entity_id": "T70",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 204,
              "end_idx": 207
            },
            {
              "entity_id": "T71",
              "entity": "长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 228,
              "end_idx": 233
            },
            {
              "entity_id": "T72",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 237,
              "end_idx": 239
            },
            {
              "entity_id": "T73",
              "entity": "1次",
              "entity_type": "Frequency",
              "start_idx": 235,
              "end_idx": 237
            },
            {
              "entity_id": "T74",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 240,
              "end_idx": 245
            },
            {
              "entity_id": "T75",
              "entity": "每日1次或2次",
              "entity_type": "Frequency",
              "start_idx": 246,
              "end_idx": 253
            },
            {
              "entity_id": "T76",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 253,
              "end_idx": 255
            },
            {
              "entity_id": "T77",
              "entity": "12~18单位",
              "entity_type": "Amount",
              "start_idx": 170,
              "end_idx": 177
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R32",
              "head_entity_id": "T68",
              "tail_entity_id": "T67"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R33",
              "head_entity_id": "T72",
              "tail_entity_id": "T71"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R34",
              "head_entity_id": "T73",
              "tail_entity_id": "T71"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R35",
              "head_entity_id": "T75",
              "tail_entity_id": "T74"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R36",
              "head_entity_id": "T76",
              "tail_entity_id": "T74"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "③每日餐时量一般按餐时总量的35%、30%、35%分配在早中晚餐前。",
          "start_idx": 256,
          "end_idx": 290,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "12",
      "paragraph": "(2)持续皮下胰岛素输注",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)持续皮下胰岛素输注",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T78",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 10
            },
            {
              "entity_id": "T79",
              "entity": "皮下",
              "entity_type": "Method",
              "start_idx": 5,
              "end_idx": 7
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R37",
              "head_entity_id": "T79",
              "tail_entity_id": "T78"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "13",
      "paragraph": "无论是直接起始胰岛素泵还是每日多次胰岛素注射方案与胰岛素泵方案的相互转换，都建议住医生指导下完成。具体用法：①初始胰岛素泵方每日胰岛素总量可按0.4~0.5单位/千克体重计算；2每日基础量=全天胰岛素总量X(40%~60%)，常规分为6或更多个时间段，以尽量减少或避免低血糖事件，或根据血糖情况分段设置基础输注率；③餐食追加量=全天胰岛素总量X(40%~60%)，根据早中晚三餐比例一般按1/3、1/3、1/3或1/5、2/5、2/5分配，之后根据血糖监测结果调整。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "无论是直接起始胰岛素泵还是每日多次胰岛素注射方案与胰岛素泵方案的相互转换，都建议住医生指导下完成。具体用法：①初始胰岛素泵方每日胰岛素总量可按0.4~0.5单位/千克体重计算；2每日基础量=全天胰岛素总量X(40%~60%)，常规分为6或更多个时间段，以尽量减少或避免低血糖事件，或根据血糖情况分段设置基础输注率；③餐食追加量=全天胰岛素总量X(40%~60%)，根据早中晚三餐比例一般按1/3、1/3、1/3或1/5、2/5、2/5分配，之后根据血糖监测结果调整。",
          "start_idx": 0,
          "end_idx": 233,
          "entities": [
            {
              "entity_id": "T80",
              "entity": "每日多次",
              "entity_type": "Frequency",
              "start_idx": 13,
              "end_idx": 17
            },
            {
              "entity_id": "T81",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T82",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 20,
              "end_idx": 22
            },
            {
              "entity_id": "T83",
              "entity": "0.4~0.5单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 71,
              "end_idx": 85
            },
            {
              "entity_id": "T84",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 134,
              "end_idx": 137
            },
            {
              "entity_id": "T85",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 224,
              "end_idx": 228
            },
            {
              "entity_id": "T86",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 64,
              "end_idx": 67
            },
            {
              "entity_id": "T87",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 143,
              "end_idx": 145
            },
            {
              "entity_id": "T88",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 166,
              "end_idx": 169
            },
            {
              "entity_id": "T89",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 97,
              "end_idx": 100
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R38",
              "head_entity_id": "T80",
              "tail_entity_id": "T81"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R39",
              "head_entity_id": "T82",
              "tail_entity_id": "T81"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R40",
              "head_entity_id": "T83",
              "tail_entity_id": "T86"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "14",
      "paragraph": "(3)特殊情况",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)特殊情况",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "15",
      "paragraph": "①蜜月期：初诊1型糖尿病患者经胰岛素规范治疗后可短期停用胰岛素或每日使用很少量胰岛素治疗，血糖水平就能维持在接近正常或正常的范围内，即1型糖尿病蜜月期。在此阶段根据血糖监测情况，可每日≤3次小剂量胰岛素(包括预混胰岛素)注射，但应以维持血糖达标为准；如出现血糖波动大、血糖不易控制，需频繁调整胰岛素用量等情况，建议及时评估胰岛功能并及时改用胰岛素强化治疗方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①蜜月期：初诊1型糖尿病患者经胰岛素规范治疗后可短期停用胰岛素或每日使用很少量胰岛素治疗，血糖水平就能维持在接近正常或正常的范围内，即1型糖尿病蜜月期。在此阶段根据血糖监测情况，可每日≤3次小剂量胰岛素(包括预混胰岛素)注射，但应以维持血糖达标为准；如出现血糖波动大、血糖不易控制，需频繁调整胰岛素用量等情况，建议及时评估胰岛功能并及时改用胰岛素强化治疗方案。",
          "start_idx": 0,
          "end_idx": 180,
          "entities": [
            {
              "entity_id": "T90",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 12
            },
            {
              "entity_id": "T91",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 7,
              "end_idx": 9
            },
            {
              "entity_id": "T92",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 18
            },
            {
              "entity_id": "T93",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 28,
              "end_idx": 31
            },
            {
              "entity_id": "T94",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 42
            },
            {
              "entity_id": "T95",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 45,
              "end_idx": 47
            },
            {
              "entity_id": "T96",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 72
            },
            {
              "entity_id": "T97",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 67,
              "end_idx": 69
            },
            {
              "entity_id": "T98",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 82,
              "end_idx": 86
            },
            {
              "entity_id": "T99",
              "entity": "每日≤3次",
              "entity_type": "Frequency",
              "start_idx": 90,
              "end_idx": 95
            },
            {
              "entity_id": "T100",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 98,
              "end_idx": 101
            },
            {
              "entity_id": "T101",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 104,
              "end_idx": 109
            },
            {
              "entity_id": "T102",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 110,
              "end_idx": 112
            },
            {
              "entity_id": "T103",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 118,
              "end_idx": 120
            },
            {
              "entity_id": "T104",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 128,
              "end_idx": 130
            },
            {
              "entity_id": "T105",
              "entity": "波动大",
              "entity_type": "Test_Value",
              "start_idx": 130,
              "end_idx": 133
            },
            {
              "entity_id": "T106",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 134,
              "end_idx": 136
            },
            {
              "entity_id": "T107",
              "entity": "不易控制",
              "entity_type": "Test_Value",
              "start_idx": 136,
              "end_idx": 140
            },
            {
              "entity_id": "T108",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 146,
              "end_idx": 149
            },
            {
              "entity_id": "T109",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 170,
              "end_idx": 173
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R41",
              "head_entity_id": "T91",
              "tail_entity_id": "T90"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R42",
              "head_entity_id": "T92",
              "tail_entity_id": "T90"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R43",
              "head_entity_id": "T95",
              "tail_entity_id": "T90"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R44",
              "head_entity_id": "T97",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R45",
              "head_entity_id": "T99",
              "tail_entity_id": "T100"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R46",
              "head_entity_id": "T99",
              "tail_entity_id": "T101"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R47",
              "head_entity_id": "T102",
              "tail_entity_id": "T100"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R48",
              "head_entity_id": "T102",
              "tail_entity_id": "T101"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "16",
      "paragraph": "②脆性糖尿病：1型糖尿病患病一段时间后由于胰岛功能完全衰竭，出现血糖巨幅波动，高血低与低血糖交替出现，频发不可预知的严重低血糖，即脆性糖尿病。少数进展迅速的患者在确诊时即可进入脆性糖尿病阶段。此类患者建议使用胰岛素泵或速效胰岛素类似物联合长效胰岛素类似物方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②脆性糖尿病：1型糖尿病患病一段时间后由于胰岛功能完全衰竭，出现血糖巨幅波动，高血低与低血糖交替出现，频发不可预知的严重低血糖，即脆性糖尿病。少数进展迅速的患者在确诊时即可进入脆性糖尿病阶段。此类患者建议使用胰岛素泵或速效胰岛素类似物联合长效胰岛素类似物方案。",
          "start_idx": 0,
          "end_idx": 130,
          "entities": [
            {
              "entity_id": "T110",
              "entity": "脆性糖尿病",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 6
            },
            {
              "entity_id": "T111",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 12
            },
            {
              "entity_id": "T112",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 7,
              "end_idx": 9
            },
            {
              "entity_id": "T113",
              "entity": "胰岛功能完全衰竭",
              "entity_type": "Reason",
              "start_idx": 21,
              "end_idx": 29
            },
            {
              "entity_id": "T114",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 32,
              "end_idx": 34
            },
            {
              "entity_id": "T115",
              "entity": "巨幅波动",
              "entity_type": "Level",
              "start_idx": 34,
              "end_idx": 38
            },
            {
              "entity_id": "T116",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 43,
              "end_idx": 46
            },
            {
              "entity_id": "T117",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 60,
              "end_idx": 63
            },
            {
              "entity_id": "T118",
              "entity": "脆性糖尿病",
              "entity_type": "Disease",
              "start_idx": 65,
              "end_idx": 70
            },
            {
              "entity_id": "T119",
              "entity": "脆性糖尿病",
              "entity_type": "Disease",
              "start_idx": 88,
              "end_idx": 93
            },
            {
              "entity_id": "T120",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 109,
              "end_idx": 117
            },
            {
              "entity_id": "T121",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 119,
              "end_idx": 127
            },
            {
              "entity_id": "T122",
              "entity": "高血低",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 42
            },
            {
              "entity_id": "T123",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 58,
              "end_idx": 60
            }
          ],
          "relations": [
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R49",
              "head_entity_id": "T113",
              "tail_entity_id": "T110"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R50",
              "head_entity_id": "T114",
              "tail_entity_id": "T110"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R51",
              "head_entity_id": "T113",
              "tail_entity_id": "T111"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R52",
              "head_entity_id": "T114",
              "tail_entity_id": "T111"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R53",
              "head_entity_id": "T112",
              "tail_entity_id": "T111"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R54",
              "head_entity_id": "T120",
              "tail_entity_id": "T119"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R55",
              "head_entity_id": "T121",
              "tail_entity_id": "T119"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "17",
      "paragraph": "③儿童青少年患者：因特殊情况无法坚持基础加餐时胰岛素治疗方案时，如短期使用预混胰岛素治疗，必须加强血糖监测，及时根据血糖情况重新调整胰岛素治疗方案，以避免长期血糖不达标带来的各种急慢性并发症。进入青春期后，一方面维持正常生长发育而不可过度严格控制饮食，另一方面体内性激素、生长激素等胰岛素拮抗激素分泌增多，因此胰岛素需要量会增加，而且患者的血糖水平会比青春期前明显升高且波动较大，需要加强血糖监测，适时调整胰岛素治疗方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "③儿童青少年患者：因特殊情况无法坚持基础加餐时胰岛素治疗方案时，如短期使用预混胰岛素治疗，必须加强血糖监测，及时根据血糖情况重新调整胰岛素治疗方案，以避免长期血糖不达标带来的各种急慢性并发症。",
          "start_idx": 0,
          "end_idx": 96,
          "entities": [
            {
              "entity_id": "T124",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 26
            },
            {
              "entity_id": "T125",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 37,
              "end_idx": 42
            },
            {
              "entity_id": "T126",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 49,
              "end_idx": 53
            },
            {
              "entity_id": "T127",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 58,
              "end_idx": 60
            },
            {
              "entity_id": "T128",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 66,
              "end_idx": 69
            },
            {
              "entity_id": "T129",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 79,
              "end_idx": 81
            },
            {
              "entity_id": "T130",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 81,
              "end_idx": 84
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "进入青春期后，一方面维持正常生长发育而不可过度严格控制饮食，另一方面体内性激素、生长激素等胰岛素拮抗激素分泌增多，因此胰岛素需要量会增加，而且患者的血糖水平会比青春期前明显升高且波动较大，需要加强血糖监测，适时调整胰岛素治疗方案。",
          "start_idx": 96,
          "end_idx": 211,
          "entities": [
            {
              "entity_id": "T131",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 62
            },
            {
              "entity_id": "T132",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 74,
              "end_idx": 76
            },
            {
              "entity_id": "T133",
              "entity": "明显升高",
              "entity_type": "Test_Value",
              "start_idx": 84,
              "end_idx": 88
            },
            {
              "entity_id": "T134",
              "entity": "波动较大",
              "entity_type": "Test_Value",
              "start_idx": 89,
              "end_idx": 93
            },
            {
              "entity_id": "T135",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 98,
              "end_idx": 102
            },
            {
              "entity_id": "T136",
              "entity": "胰岛素",
              "entity_type": "Test_items",
              "start_idx": 107,
              "end_idx": 110
            },
            {
              "entity_id": "T137",
              "entity": "控制饮食",
              "entity_type": "Treatment",
              "start_idx": 25,
              "end_idx": 29
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "18",
      "paragraph": "④妊娠患者：合并妊娠时可采用短效胰岛素、中效胰岛素或长效胰岛素进行方案组合，或使用胰岛泵治疗。目前经国家食品药品监督管理总局(CFDA)批准可用于妊娠糖尿病和糖尿病合并妊娠患者的胰岛素类似物制剂是门冬胰岛素和地特胰岛素。与2型糖尿病患者妊娠期间的情况类似，由于激素水平的变化，妊娠中后期胰岛素需要量，尤其是日间胰岛素需要量会增加，而随着胎盘娩出，拮抗胰岛素的激素及破坏胰岛素的酶急剧减少或消失，胰岛素需要量会快速减少，一般分娩后2~3天胰岛素可减量至原量的1/3~1/2。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "④妊娠患者：合并妊娠时可采用短效胰岛素、中效胰岛素或长效胰岛素进行方案组合，或使用胰岛泵治疗。目前经国家食品药品监督管理总局(CFDA)批准可用于妊娠糖尿病和糖尿病合并妊娠患者的胰岛素类似物制剂是门冬胰岛素和地特胰岛素。与2型糖尿病患者妊娠期间的情况类似，由于激素水平的变化，妊娠中后期胰岛素需要量，尤其是日间胰岛素需要量会增加，而随着胎盘娩出，拮抗胰岛素的激素及破坏胰岛素的酶急剧减少或消失，胰岛素需要量会快速减少，一般分娩后2~3天胰岛素可减量至原量的1/3~1/2。",
          "start_idx": 0,
          "end_idx": 236,
          "entities": [
            {
              "entity_id": "T138",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 19
            },
            {
              "entity_id": "T139",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 25
            },
            {
              "entity_id": "T140",
              "entity": "长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 26,
              "end_idx": 31
            },
            {
              "entity_id": "T141",
              "entity": "妊娠糖尿病",
              "entity_type": "Disease",
              "start_idx": 73,
              "end_idx": 78
            },
            {
              "entity_id": "T142",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 79,
              "end_idx": 82
            },
            {
              "entity_id": "T143",
              "entity": "胰岛素类似物制剂",
              "entity_type": "Drug",
              "start_idx": 89,
              "end_idx": 97
            },
            {
              "entity_id": "T144",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 98,
              "end_idx": 103
            },
            {
              "entity_id": "T145",
              "entity": "地特胰岛素",
              "entity_type": "Drug",
              "start_idx": 104,
              "end_idx": 109
            },
            {
              "entity_id": "T146",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 111,
              "end_idx": 116
            },
            {
              "entity_id": "T147",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 111,
              "end_idx": 113
            },
            {
              "entity_id": "T148",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 143,
              "end_idx": 146
            },
            {
              "entity_id": "T149",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 155,
              "end_idx": 158
            },
            {
              "entity_id": "T150",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 197,
              "end_idx": 200
            },
            {
              "entity_id": "T151",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 218,
              "end_idx": 221
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R56",
              "head_entity_id": "T143",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R57",
              "head_entity_id": "T144",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R58",
              "head_entity_id": "T145",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R59",
              "head_entity_id": "T143",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R60",
              "head_entity_id": "T144",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R61",
              "head_entity_id": "T145",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R62",
              "head_entity_id": "T147",
              "tail_entity_id": "T146"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R63",
              "head_entity_id": "T148",
              "tail_entity_id": "T146"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "19",
      "paragraph": "⑤超重或肥胖患者：胰岛素抵抗会导致胰岛素需要量增加，必要时可联合二甲双胍(10岁以下儿童禁用)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "⑤超重或肥胖患者：胰岛素抵抗会导致胰岛素需要量增加，必要时可联合二甲双胍(10岁以下儿童禁用)。",
          "start_idx": 0,
          "end_idx": 48,
          "entities": [
            {
              "entity_id": "T152",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T153",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 6
            },
            {
              "entity_id": "T154",
              "entity": "胰岛素抵抗",
              "entity_type": "Pathogenesis",
              "start_idx": 9,
              "end_idx": 14
            },
            {
              "entity_id": "T155",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T156",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 36
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R64",
              "head_entity_id": "T155",
              "tail_entity_id": "T152"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R65",
              "head_entity_id": "T156",
              "tail_entity_id": "T152"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R66",
              "head_entity_id": "T155",
              "tail_entity_id": "T153"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R67",
              "head_entity_id": "T156",
              "tail_entity_id": "T153"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "20",
      "paragraph": "2型糖尿病：(《成人2型糖尿病胰岛素临床应用的中国专家共识(2013年版)》)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2型糖尿病：(《成人2型糖尿病胰岛素临床应用的中国专家共识(2013年版)》)",
          "start_idx": 0,
          "end_idx": 39,
          "entities": [
            {
              "entity_id": "T157",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 0,
              "end_idx": 2
            },
            {
              "entity_id": "T158",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T159",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T160",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 10,
              "end_idx": 12
            },
            {
              "entity_id": "T161",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R68",
              "head_entity_id": "T157",
              "tail_entity_id": "T158"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R69",
              "head_entity_id": "T160",
              "tail_entity_id": "T159"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R70",
              "head_entity_id": "T161",
              "tail_entity_id": "T159"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "21",
      "paragraph": "中国特色",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "中国特色",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "22",
      "paragraph": "首先来说，东西方2型糖尿病人群的病生理特点及血糖特点有所不同：西方白种人的日常饮食中脂肪含量较高，胰岛素抵抗和腹型肥胖尤为突出，空腹血糖升高更为明显；而中国人群的饮食以碳水化合物为主，β细胞功能缺陷相对更为明显，胰岛素分泌和储备能力低，尤其是胰岛素早相分泌减退更严重，餐后血糖升高显著，不仅如此，体质指数(BMI)虽然相对较低但腹部脂肪蓄积较多，高糖高脂毒性及氧化应激等对β细胞的伤害更明显。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "首先来说，东西方2型糖尿病人群的病生理特点及血糖特点有所不同：西方白种人的日常饮食中脂肪含量较高，胰岛素抵抗和腹型肥胖尤为突出，空腹血糖升高更为明显；而中国人群的饮食以碳水化合物为主，β细胞功能缺陷相对更为明显，胰岛素分泌和储备能力低，尤其是胰岛素早相分泌减退更严重，餐后血糖升高显著，不仅如此，体质指数(BMI)虽然相对较低但腹部脂肪蓄积较多，高糖高脂毒性及氧化应激等对β细胞的伤害更明显。",
          "start_idx": 0,
          "end_idx": 196,
          "entities": [
            {
              "entity_id": "T162",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T163",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 8,
              "end_idx": 10
            },
            {
              "entity_id": "T164",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 22,
              "end_idx": 24
            },
            {
              "entity_id": "T165",
              "entity": "胰岛素抵抗",
              "entity_type": "Pathogenesis",
              "start_idx": 49,
              "end_idx": 54
            },
            {
              "entity_id": "T166",
              "entity": "腹型肥胖",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 59
            },
            {
              "entity_id": "T167",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 64,
              "end_idx": 68
            },
            {
              "entity_id": "T168",
              "entity": "升高",
              "entity_type": "Level",
              "start_idx": 68,
              "end_idx": 70
            },
            {
              "entity_id": "T169",
              "entity": "β细胞功能缺陷",
              "entity_type": "Pathogenesis",
              "start_idx": 92,
              "end_idx": 99
            },
            {
              "entity_id": "T170",
              "entity": "胰岛素分泌和储备能力低",
              "entity_type": "Pathogenesis",
              "start_idx": 106,
              "end_idx": 117
            },
            {
              "entity_id": "T171",
              "entity": "胰岛素早相分泌减退",
              "entity_type": "Pathogenesis",
              "start_idx": 121,
              "end_idx": 130
            },
            {
              "entity_id": "T172",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 134,
              "end_idx": 138
            },
            {
              "entity_id": "T173",
              "entity": "升高显著",
              "entity_type": "Test_Value",
              "start_idx": 138,
              "end_idx": 142
            },
            {
              "entity_id": "T174",
              "entity": "饮食中脂肪含量较高",
              "entity_type": "Reason",
              "start_idx": 39,
              "end_idx": 48
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R71",
              "head_entity_id": "T163",
              "tail_entity_id": "T162"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R72",
              "head_entity_id": "T164",
              "tail_entity_id": "T162"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R73",
              "head_entity_id": "T165",
              "tail_entity_id": "T162"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R74",
              "head_entity_id": "T167",
              "tail_entity_id": "T162"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R75",
              "head_entity_id": "T174",
              "tail_entity_id": "T162"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "23",
      "paragraph": "由此所带来的就是东西方2型糖尿病人群的胰岛素治疗理念也应有所不同：西方2型糖尿病的治疗主要是以改善胰岛素抵抗和补充基础胰岛素为主的起始治疗，例如，多数国家和地区的指南均推荐起始使用基础胰岛素，像美国糖尿病协会(ADA)/欧洲糖尿究学会(EASD)联合共识、中国台湾糖尿病临床照护指引、英国国家健康与临床优化研究所(ICE)临床指南、国际糖尿病联盟(IDF)欧洲指南；而美国内分泌医师协会/美国内分泌学会(AACE/ACE)专家共识则指出基础胰岛素、预混胰岛素、基础-餐时胰岛素或餐时胰岛素一日多次注射、餐时胰岛素加二甲双胍这四种胰岛素方案中任一种均可作为起始治疗。《成人2糖尿病胰岛素临床应用的中国专家共识》的一个主要特点就是提出，中国2型糖尿病患者更需要适时启胰岛素治疗，而且基于餐后血糖更为常见，在干预策略上，应同时针对β细胞功能缺陷和胰岛素作用障碍两个方面，兼顾基础和餐时胰岛素；同时考虑我国2型糖尿病患者的疾病特点和现实社会因素，推荐基础胰岛素和预混胰岛素均可作为口服药失效或血糖较高的新诊断2型糖尿病患者的一线治疗方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由此所带来的就是东西方2型糖尿病人群的胰岛素治疗理念也应有所不同：西方2型糖尿病的治疗主要是以改善胰岛素抵抗和补充基础胰岛素为主的起始治疗，例如，多数国家和地区的指南均推荐起始使用基础胰岛素，像美国糖尿病协会(ADA)/欧洲糖尿究学会(EASD)联合共识、中国台湾糖尿病临床照护指引、英国国家健康与临床优化研究所(ICE)临床指南、国际糖尿病联盟(IDF)欧洲指南；而美国内分泌医师协会/美国内分泌学会(AACE/ACE)专家共识则指出基础胰岛素、预混胰岛素、基础-餐时胰岛素或餐时胰岛素一日多次注射、餐时胰岛素加二甲双胍这四种胰岛素方案中任一种均可作为起始治疗。《成人2糖尿病胰岛素临床应用的中国专家共识》的一个主要特点就是提出，中国2型糖尿病患者更需要适时启胰岛素治疗，而且基于餐后血糖更为常见，在干预策略上，应同时针对β细胞功能缺陷和胰岛素作用障碍两个方面，兼顾基础和餐时胰岛素；同时考虑我国2型糖尿病患者的疾病特点和现实社会因素，推荐基础胰岛素和预混胰岛素均可作为口服药失效或血糖较高的新诊断2型糖尿病患者的一线治疗方案。",
          "start_idx": 0,
          "end_idx": 465,
          "entities": [
            {
              "entity_id": "T175",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 16
            },
            {
              "entity_id": "T176",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T177",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 22
            },
            {
              "entity_id": "T178",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 40
            },
            {
              "entity_id": "T179",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 35,
              "end_idx": 37
            },
            {
              "entity_id": "T180",
              "entity": "胰岛素抵抗",
              "entity_type": "Pathogenesis",
              "start_idx": 49,
              "end_idx": 54
            },
            {
              "entity_id": "T181",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 62
            },
            {
              "entity_id": "T182",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 92,
              "end_idx": 95
            },
            {
              "entity_id": "T183",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 132,
              "end_idx": 135
            },
            {
              "entity_id": "T184",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 168,
              "end_idx": 171
            },
            {
              "entity_id": "T185",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 220,
              "end_idx": 223
            },
            {
              "entity_id": "T186",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 224,
              "end_idx": 229
            },
            {
              "entity_id": "T187",
              "entity": "基础-餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 230,
              "end_idx": 238
            },
            {
              "entity_id": "T188",
              "entity": "一日多次",
              "entity_type": "Frequency",
              "start_idx": 244,
              "end_idx": 248
            },
            {
              "entity_id": "T189",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 248,
              "end_idx": 250
            },
            {
              "entity_id": "T190",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 239,
              "end_idx": 244
            },
            {
              "entity_id": "T191",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 251,
              "end_idx": 256
            },
            {
              "entity_id": "T192",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 257,
              "end_idx": 261
            },
            {
              "entity_id": "T193",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 264,
              "end_idx": 267
            },
            {
              "entity_id": "T194",
              "entity": "2糖尿病",
              "entity_type": "Disease",
              "start_idx": 285,
              "end_idx": 289
            },
            {
              "entity_id": "T195",
              "entity": "2糖",
              "entity_type": "Class",
              "start_idx": 285,
              "end_idx": 287
            },
            {
              "entity_id": "T196",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 289,
              "end_idx": 292
            },
            {
              "entity_id": "T197",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 318,
              "end_idx": 323
            },
            {
              "entity_id": "T198",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 318,
              "end_idx": 320
            },
            {
              "entity_id": "T199",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 331,
              "end_idx": 334
            },
            {
              "entity_id": "T200",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 341,
              "end_idx": 345
            },
            {
              "entity_id": "T201",
              "entity": "β细胞功能缺陷",
              "entity_type": "Pathogenesis",
              "start_idx": 362,
              "end_idx": 369
            },
            {
              "entity_id": "T202",
              "entity": "胰岛素作用障碍",
              "entity_type": "Pathogenesis",
              "start_idx": 370,
              "end_idx": 377
            },
            {
              "entity_id": "T203",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 387,
              "end_idx": 392
            },
            {
              "entity_id": "T204",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 399,
              "end_idx": 404
            },
            {
              "entity_id": "T205",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 399,
              "end_idx": 401
            },
            {
              "entity_id": "T206",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 423,
              "end_idx": 426
            },
            {
              "entity_id": "T207",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 427,
              "end_idx": 432
            },
            {
              "entity_id": "T208",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 442,
              "end_idx": 444
            },
            {
              "entity_id": "T209",
              "entity": "较高",
              "entity_type": "Test_Value",
              "start_idx": 444,
              "end_idx": 446
            },
            {
              "entity_id": "T210",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 450,
              "end_idx": 455
            },
            {
              "entity_id": "T211",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 450,
              "end_idx": 452
            },
            {
              "entity_id": "T212",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 99,
              "end_idx": 102
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R76",
              "head_entity_id": "T176",
              "tail_entity_id": "T175"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R77",
              "head_entity_id": "T177",
              "tail_entity_id": "T175"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R78",
              "head_entity_id": "T179",
              "tail_entity_id": "T178"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R79",
              "head_entity_id": "T180",
              "tail_entity_id": "T178"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R80",
              "head_entity_id": "T181",
              "tail_entity_id": "T178"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R81",
              "head_entity_id": "T188",
              "tail_entity_id": "T185"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R82",
              "head_entity_id": "T189",
              "tail_entity_id": "T185"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R83",
              "head_entity_id": "T188",
              "tail_entity_id": "T186"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R84",
              "head_entity_id": "T189",
              "tail_entity_id": "T186"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R85",
              "head_entity_id": "T188",
              "tail_entity_id": "T187"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R86",
              "head_entity_id": "T189",
              "tail_entity_id": "T187"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R87",
              "head_entity_id": "T188",
              "tail_entity_id": "T190"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R88",
              "head_entity_id": "T189",
              "tail_entity_id": "T190"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R89",
              "head_entity_id": "T195",
              "tail_entity_id": "T194"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R90",
              "head_entity_id": "T196",
              "tail_entity_id": "T194"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R91",
              "head_entity_id": "T198",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R92",
              "head_entity_id": "T199",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R93",
              "head_entity_id": "T200",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R94",
              "head_entity_id": "T201",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R95",
              "head_entity_id": "T202",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R96",
              "head_entity_id": "T203",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R97",
              "head_entity_id": "T205",
              "tail_entity_id": "T204"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R98",
              "head_entity_id": "T206",
              "tail_entity_id": "T204"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R99",
              "head_entity_id": "T207",
              "tail_entity_id": "T204"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R100",
              "head_entity_id": "T208",
              "tail_entity_id": "T204"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R101",
              "head_entity_id": "T211",
              "tail_entity_id": "T210"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "24",
      "paragraph": "适用人群",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "适用人群",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "25",
      "paragraph": "该共识建议，对于2型糖尿病患者，以下情况应给予胰岛素治疗(暂不考虑口服降糖药治疗)：(1)急性并发症或严重慢性并发症；(2)应激情况(感染、外伤、手术等)；(3)严重合并症，肝肾功能不全； (4)妊娠期间。而以下情况可给予胰岛素单药治疗，亦可给予口服药和胰岛素联合应用：(1)新诊断2型糖尿病患者，糖化血红蛋白(HbA1c)≥9.0%且糖尿病症状明显；(2)在采用有效的生活方式干预及2种或2种以上口服降糖药次大剂量治疗3个月后血糖仍不达标(HbA1c≥7.0%)患者；(3)病程中出现无确切诱因的体重下降者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "该共识建议，对于2型糖尿病患者，以下情况应给予胰岛素治疗(暂不考虑口服降糖药治疗)：(1)急性并发症或严重慢性并发症；(2)应激情况(感染、外伤、手术等)；(3)严重合并症，肝肾功能不全； (4)妊娠期间。而以下情况可给予胰岛素单药治疗，亦可给予口服药和胰岛素联合应用：(1)新诊断2型糖尿病患者，糖化血红蛋白(HbA1c)≥9.0%且糖尿病症状明显；(2)在采用有效的生活方式干预及2种或2种以上口服降糖药次大剂量治疗3个月后血糖仍不达标(HbA1c≥7.0%)患者；(3)病程中出现无确切诱因的体重下降者。",
          "start_idx": 0,
          "end_idx": 255,
          "entities": [
            {
              "entity_id": "T213",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T214",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 8,
              "end_idx": 10
            },
            {
              "entity_id": "T215",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 26
            },
            {
              "entity_id": "T216",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 111,
              "end_idx": 114
            },
            {
              "entity_id": "T217",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 127,
              "end_idx": 130
            },
            {
              "entity_id": "T218",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 141,
              "end_idx": 146
            },
            {
              "entity_id": "T219",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 141,
              "end_idx": 143
            },
            {
              "entity_id": "T220",
              "entity": "糖化血红蛋白(HbA1c)",
              "entity_type": "Test_items",
              "start_idx": 149,
              "end_idx": 162
            },
            {
              "entity_id": "T221",
              "entity": "≥9.0%",
              "entity_type": "Test_Value",
              "start_idx": 162,
              "end_idx": 167
            },
            {
              "entity_id": "T222",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 168,
              "end_idx": 171
            },
            {
              "entity_id": "T223",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 185,
              "end_idx": 191
            },
            {
              "entity_id": "T224",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 214,
              "end_idx": 216
            },
            {
              "entity_id": "T225",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 217,
              "end_idx": 220
            },
            {
              "entity_id": "T226",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 221,
              "end_idx": 226
            },
            {
              "entity_id": "T227",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 226,
              "end_idx": 231
            },
            {
              "entity_id": "T228",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 33,
              "end_idx": 35
            },
            {
              "entity_id": "T229",
              "entity": "肝肾功能不全",
              "entity_type": "Disease",
              "start_idx": 87,
              "end_idx": 93
            },
            {
              "entity_id": "T230",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 87,
              "end_idx": 88
            },
            {
              "entity_id": "T231",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 88,
              "end_idx": 89
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R102",
              "head_entity_id": "T214",
              "tail_entity_id": "T213"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R103",
              "head_entity_id": "T215",
              "tail_entity_id": "T213"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R104",
              "head_entity_id": "T217",
              "tail_entity_id": "T218"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R105",
              "head_entity_id": "T219",
              "tail_entity_id": "T218"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R106",
              "head_entity_id": "T220",
              "tail_entity_id": "T218"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R107",
              "head_entity_id": "T230",
              "tail_entity_id": "T229"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R108",
              "head_entity_id": "T231",
              "tail_entity_id": "T229"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "26",
      "paragraph": "临床用法",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床用法",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "27",
      "paragraph": "(1)基本原则",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)基本原则",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "28",
      "paragraph": "该共识的另一个显著特点就是强调要综合考虑疗效与安全性、患者病情与能力、支付能力(经济水平和医疗保障)等多种因素，选择适宜的治疗方案，详见表2和图1。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "该共识的另一个显著特点就是强调要综合考虑疗效与安全性、患者病情与能力、支付能力(经济水平和医疗保障)等多种因素，选择适宜的治疗方案，详见表2和图1。",
          "start_idx": 0,
          "end_idx": 74,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "29",
      "paragraph": "(2)联合用药",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)联合用药",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "30",
      "paragraph": "药物的合理联用可以避免或减少药物不良反应产生。该共识推荐采用胰岛素/口服药联合方案以增加降糖疗效，同时减少胰岛素治疗潜在的低血糖和体重增加的不良反应。二甲双胍与胰岛素联用可减少体重增加，减少外源性胰岛素用量；葡萄糖苷酶抑制剂与胰岛素联用在有效改善血糖的同时，可减少胰岛素用量，减少体重增加的幅度和趋势。因此，在无禁忌证的2型糖尿病患者中均可采用二甲双胍或糖苷酶抑制剂与胰岛素联用。而胰岛素促泌剂也潜在有低血糖和体重增加的不良反应，所以除基础胰岛素外，不建议其与胰岛素联用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "药物的合理联用可以避免或减少药物不良反应产生。",
          "start_idx": 0,
          "end_idx": 23,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "该共识推荐采用胰岛素/口服药联合方案以增加降糖疗效，同时减少胰岛素治疗潜在的低血糖和体重增加的不良反应。二甲双胍与胰岛素联用可减少体重增加，减少外源性胰岛素用量；葡萄糖苷酶抑制剂与胰岛素联用在有效改善血糖的同时，可减少胰岛素用量，减少体重增加的幅度和趋势。因此，在无禁忌证的2型糖尿病患者中均可采用二甲双胍或糖苷酶抑制剂与胰岛素联用。",
          "start_idx": 23,
          "end_idx": 190,
          "entities": [
            {
              "entity_id": "T232",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 10
            },
            {
              "entity_id": "T233",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 33
            },
            {
              "entity_id": "T234",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 38,
              "end_idx": 41
            },
            {
              "entity_id": "T235",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 42,
              "end_idx": 46
            },
            {
              "entity_id": "T236",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 52,
              "end_idx": 56
            },
            {
              "entity_id": "T237",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 57,
              "end_idx": 60
            },
            {
              "entity_id": "T238",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 65,
              "end_idx": 69
            },
            {
              "entity_id": "T239",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 75,
              "end_idx": 78
            },
            {
              "entity_id": "T240",
              "entity": "葡萄糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 81,
              "end_idx": 89
            },
            {
              "entity_id": "T241",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 90,
              "end_idx": 93
            },
            {
              "entity_id": "T242",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 102
            },
            {
              "entity_id": "T243",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 109,
              "end_idx": 112
            },
            {
              "entity_id": "T244",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 117,
              "end_idx": 121
            },
            {
              "entity_id": "T245",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 137,
              "end_idx": 142
            },
            {
              "entity_id": "T246",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 137,
              "end_idx": 139
            },
            {
              "entity_id": "T247",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 149,
              "end_idx": 153
            },
            {
              "entity_id": "T248",
              "entity": "糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 154,
              "end_idx": 160
            },
            {
              "entity_id": "T249",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 161,
              "end_idx": 164
            },
            {
              "entity_id": "T255",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 11,
              "end_idx": 13
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R109",
              "head_entity_id": "T234",
              "tail_entity_id": "T233"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R110",
              "head_entity_id": "T235",
              "tail_entity_id": "T233"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R111",
              "head_entity_id": "T246",
              "tail_entity_id": "T245"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R112",
              "head_entity_id": "T247",
              "tail_entity_id": "T245"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R113",
              "head_entity_id": "T248",
              "tail_entity_id": "T245"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R114",
              "head_entity_id": "T249",
              "tail_entity_id": "T245"
            }
          ]
        },
        {
          "sentence_id": "2",
          "sentence": "而胰岛素促泌剂也潜在有低血糖和体重增加的不良反应，所以除基础胰岛素外，不建议其与胰岛素联用。",
          "start_idx": 190,
          "end_idx": 236,
          "entities": [
            {
              "entity_id": "T250",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 7
            },
            {
              "entity_id": "T251",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 11,
              "end_idx": 14
            },
            {
              "entity_id": "T252",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 15,
              "end_idx": 19
            },
            {
              "entity_id": "T253",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 33
            },
            {
              "entity_id": "T254",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 40,
              "end_idx": 43
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R115",
              "head_entity_id": "T251",
              "tail_entity_id": "T250"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R116",
              "head_entity_id": "T252",
              "tail_entity_id": "T250"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "31",
      "paragraph": "(3)特殊情况",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)特殊情况",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "32",
      "paragraph": "①肥胖患者：共识指出，在积极使用胰岛素同时，还应注意合理使用以避免过度应用，对于肥胖(BMl>28千克/米2)的患者，应在口服药充分治疗的基础上再考虑起始胰岛素治疗。2低血糖风险：对已合并心脑血管疾病或危险因素的2型糖尿病患者，或是老年糖尿病患者，过于激进的降糖治疗可能产生潜在的风险，进而抵消或掩盖其潜在的心血管获益。由于脑组织代谢的特殊性，卒中患者对低血糖的耐受性更低。然而脑血管疾病在我国发病率显著高于西方国家，因此在使用胰岛素时，更加需要注意采取相对宽松的降糖治疗策略与目标值，避免低血糖的发生。③肾功能不全患者：这类患者的肾脏对胰岛素的降解明显减少，同时胰岛素排出速率下降，胰岛素可能在体内蓄积，患者出现氮质血症时[血液中尿素氮超过9毫摩尔/升(mmol/L)、肌酐超过178微摩尔/升(μmol/L)]应根据血糖监测情况及时减少和调整胰岛素用量，使血糖维持在适当范围内，并且优先选择短效或速效胰岛素剂型。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①肥胖患者：共识指出，在积极使用胰岛素同时，还应注意合理使用以避免过度应用，对于肥胖(BMl>28千克/米2)的患者，应在口服药充分治疗的基础上再考虑起始胰岛素治疗。2低血糖风险：对已合并心脑血管疾病或危险因素的2型糖尿病患者，或是老年糖尿病患者，过于激进的降糖治疗可能产生潜在的风险，进而抵消或掩盖其潜在的心血管获益。由于脑组织代谢的特殊性，卒中患者对低血糖的耐受性更低。然而脑血管疾病在我国发病率显著高于西方国家，因此在使用胰岛素时，更加需要注意采取相对宽松的降糖治疗策略与目标值，避免低血糖的发生。",
          "start_idx": 0,
          "end_idx": 252,
          "entities": [
            {
              "entity_id": "T256",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T257",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 19
            },
            {
              "entity_id": "T258",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 40,
              "end_idx": 42
            },
            {
              "entity_id": "T259",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 77,
              "end_idx": 80
            },
            {
              "entity_id": "T260",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 84,
              "end_idx": 87
            },
            {
              "entity_id": "T261",
              "entity": "心脑血管疾病",
              "entity_type": "Disease",
              "start_idx": 94,
              "end_idx": 100
            },
            {
              "entity_id": "T262",
              "entity": "心脑血管",
              "entity_type": "Anatomy",
              "start_idx": 94,
              "end_idx": 98
            },
            {
              "entity_id": "T263",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 106,
              "end_idx": 111
            },
            {
              "entity_id": "T264",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 106,
              "end_idx": 108
            },
            {
              "entity_id": "T265",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 118,
              "end_idx": 121
            },
            {
              "entity_id": "T266",
              "entity": "卒中",
              "entity_type": "Disease",
              "start_idx": 172,
              "end_idx": 174
            },
            {
              "entity_id": "T267",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 177,
              "end_idx": 180
            },
            {
              "entity_id": "T268",
              "entity": "脑血管疾病",
              "entity_type": "Disease",
              "start_idx": 189,
              "end_idx": 194
            },
            {
              "entity_id": "T269",
              "entity": "脑血管",
              "entity_type": "Anatomy",
              "start_idx": 189,
              "end_idx": 192
            },
            {
              "entity_id": "T270",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 214,
              "end_idx": 217
            },
            {
              "entity_id": "T271",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 245,
              "end_idx": 248
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R117",
              "head_entity_id": "T262",
              "tail_entity_id": "T261"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R118",
              "head_entity_id": "T264",
              "tail_entity_id": "T263"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R119",
              "head_entity_id": "T269",
              "tail_entity_id": "T268"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R120",
              "head_entity_id": "T271",
              "tail_entity_id": "T270"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "③肾功能不全患者：这类患者的肾脏对胰岛素的降解明显减少，同时胰岛素排出速率下降，胰岛素可能在体内蓄积，患者出现氮质血症时[血液中尿素氮超过9毫摩尔/升(mmol/L)、肌酐超过178微摩尔/升(μmol/L)]应根据血糖监测情况及时减少和调整胰岛素用量，使血糖维持在适当范围内，并且优先选择短效或速效胰岛素剂型。",
          "start_idx": 252,
          "end_idx": 408,
          "entities": [
            {
              "entity_id": "T272",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 6
            },
            {
              "entity_id": "T273",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 1,
              "end_idx": 2
            },
            {
              "entity_id": "T274",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T275",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 33
            },
            {
              "entity_id": "T276",
              "entity": "氮质血症",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 59
            },
            {
              "entity_id": "T277",
              "entity": "尿素氮",
              "entity_type": "Test_items",
              "start_idx": 64,
              "end_idx": 67
            },
            {
              "entity_id": "T278",
              "entity": "超过9毫摩尔/升(mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 67,
              "end_idx": 82
            },
            {
              "entity_id": "T279",
              "entity": "肌酐",
              "entity_type": "Test_items",
              "start_idx": 84,
              "end_idx": 86
            },
            {
              "entity_id": "T280",
              "entity": "超过178微摩尔/升(μmol/L",
              "entity_type": "Test_Value",
              "start_idx": 86,
              "end_idx": 103
            },
            {
              "entity_id": "T281",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 108,
              "end_idx": 112
            },
            {
              "entity_id": "T282",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 121,
              "end_idx": 124
            },
            {
              "entity_id": "T283",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 128,
              "end_idx": 130
            },
            {
              "entity_id": "T284",
              "entity": "速效胰岛素",
              "entity_type": "Drug",
              "start_idx": 148,
              "end_idx": 153
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R121",
              "head_entity_id": "T273",
              "tail_entity_id": "T272"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "33",
      "paragraph": "餐时胰岛素：《速效胰岛素类似物临床应用专家指导意见》",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "餐时胰岛素：《速效胰岛素类似物临床应用专家指导意见》",
          "start_idx": 0,
          "end_idx": 26,
          "entities": [
            {
              "entity_id": "T285",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 15
            },
            {
              "entity_id": "T286",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 5
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "34",
      "paragraph": "临床上应用的胰岛素制剂历经两次换代，即动物胰岛素-人胰岛素-胰岛素类似物，更新换代的目的就是希望能够更好地模拟生理性胰岛素分泌，以速效胰岛素类似物为例，其与短效人胰岛素同为模拟餐时胰岛素分泌，但在控制血糖和减少低血糖风险等方面均优于后者，而且可以餐前即刻注射更为方便，能够提高患者的治疗依从性。2016年，多位国内内分泌专家联合发布了《速效胰岛素类似物临床应用专家指导意见》，旨在指导速效胰岛素类似物的合理使用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床上应用的胰岛素制剂历经两次换代，即动物胰岛素-人胰岛素-胰岛素类似物，更新换代的目的就是希望能够更好地模拟生理性胰岛素分泌，以速效胰岛素类似物为例，其与短效人胰岛素同为模拟餐时胰岛素分泌，但在控制血糖和减少低血糖风险等方面均优于后者，而且可以餐前即刻注射更为方便，能够提高患者的治疗依从性。",
          "start_idx": 0,
          "end_idx": 147,
          "entities": [
            {
              "entity_id": "T287",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T288",
              "entity": "动物胰岛素",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 24
            },
            {
              "entity_id": "T289",
              "entity": "人胰岛素",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T290",
              "entity": "胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 36
            },
            {
              "entity_id": "T291",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 61
            },
            {
              "entity_id": "T292",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 65,
              "end_idx": 73
            },
            {
              "entity_id": "T293",
              "entity": "短效人胰岛素",
              "entity_type": "Drug",
              "start_idx": 78,
              "end_idx": 84
            },
            {
              "entity_id": "T294",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 90,
              "end_idx": 93
            },
            {
              "entity_id": "T295",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 102
            },
            {
              "entity_id": "T296",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 105,
              "end_idx": 108
            },
            {
              "entity_id": "T299",
              "entity": "餐前即刻注射",
              "entity_type": "Method",
              "start_idx": 123,
              "end_idx": 129
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R122",
              "head_entity_id": "T299",
              "tail_entity_id": "T293"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R123",
              "head_entity_id": "T296",
              "tail_entity_id": "T294"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "2016年，多位国内内分泌专家联合发布了《速效胰岛素类似物临床应用专家指导意见》，旨在指导速效胰岛素类似物的合理使用。",
          "start_idx": 147,
          "end_idx": 206,
          "entities": [
            {
              "entity_id": "T297",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 29
            },
            {
              "entity_id": "T298",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 45,
              "end_idx": 53
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "35",
      "paragraph": "作用特点",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "作用特点",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "36",
      "paragraph": "正常人的胰岛素分泌包括基础性的持续分泌和外源性刺激后(主要是进餐)的餐时分泌两部分，两者大约各占全天总量的一半。前者的主要作用是调节空腹和餐前血糖，后者的主要作用是控制餐后血糖。餐时胰岛素又可以细分为早相(第一时相)和晚相(第二时相)分泌，其中早相分泌的速度和分泌量是决定餐后血糖升高幅度和持续时间的主要因素。2型糖尿病早期阶段主要是早相分泌减少，同时伴有晚相分泌代偿性增加且分泌高峰后移；随着病情进展，早相分泌进减少甚至消失，而晚相分泌峰值也逐渐下降，最后发展至基础分泌也逐渐减少。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "正常人的胰岛素分泌包括基础性的持续分泌和外源性刺激后(主要是进餐)的餐时分泌两部分，两者大约各占全天总量的一半。前者的主要作用是调节空腹和餐前血糖，后者的主要作用是控制餐后血糖。餐时胰岛素又可以细分为早相(第一时相)和晚相(第二时相)分泌，其中早相分泌的速度和分泌量是决定餐后血糖升高幅度和持续时间的主要因素。2型糖尿病早期阶段主要是早相分泌减少，同时伴有晚相分泌代偿性增加且分泌高峰后移；随着病情进展，早相分泌进减少甚至消失，而晚相分泌峰值也逐渐下降，最后发展至基础分泌也逐渐减少。",
          "start_idx": 0,
          "end_idx": 242,
          "entities": [
            {
              "entity_id": "T300",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 69,
              "end_idx": 73
            },
            {
              "entity_id": "T301",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 84,
              "end_idx": 88
            },
            {
              "entity_id": "T302",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 136,
              "end_idx": 140
            },
            {
              "entity_id": "T303",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 140,
              "end_idx": 142
            },
            {
              "entity_id": "T304",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 155,
              "end_idx": 160
            },
            {
              "entity_id": "T305",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 155,
              "end_idx": 157
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R124",
              "head_entity_id": "T305",
              "tail_entity_id": "T304"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "37",
      "paragraph": "由此可见，胰岛素早相分泌异常不仅是2型糖病的早期表现，并将持续整个病程，同时也是餐后高血糖的主要原因。《中国2型糖尿病患者餐后高血糖管理专家共识》建议，短效人胰岛素和速效胰岛素类似物均可用于补充餐时胰岛素的不足以控制餐后高血糖。不过如前所述，速效胰岛素类似物由于起效、达峰和峰效时间更为合理，所以具有更大的治疗优势。目前国内临床上应用的速效胰岛素类似物主要有门冬胰岛素、赖脯胰岛素和谷赖胰岛素，详见见表3。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由此可见，胰岛素早相分泌异常不仅是2型糖病的早期表现，并将持续整个病程，同时也是餐后高血糖的主要原因。《中国2型糖尿病患者餐后高血糖管理专家共识》建议，短效人胰岛素和速效胰岛素类似物均可用于补充餐时胰岛素的不足以控制餐后高血糖。",
          "start_idx": 0,
          "end_idx": 114,
          "entities": [
            {
              "entity_id": "T306",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 42,
              "end_idx": 45
            },
            {
              "entity_id": "T307",
              "entity": "胰岛素早相分泌异常",
              "entity_type": "Pathogenesis",
              "start_idx": 5,
              "end_idx": 14
            },
            {
              "entity_id": "T308",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 54,
              "end_idx": 59
            },
            {
              "entity_id": "T309",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 54,
              "end_idx": 56
            },
            {
              "entity_id": "T310",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 63,
              "end_idx": 66
            },
            {
              "entity_id": "T311",
              "entity": "短效人胰岛素",
              "entity_type": "Drug",
              "start_idx": 76,
              "end_idx": 82
            },
            {
              "entity_id": "T312",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 83,
              "end_idx": 91
            },
            {
              "entity_id": "T313",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 110,
              "end_idx": 113
            },
            {
              "entity_id": "T319",
              "entity": "2型糖病",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 21
            },
            {
              "entity_id": "T320",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 17,
              "end_idx": 19
            }
          ],
          "relations": [
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R125",
              "head_entity_id": "T307",
              "tail_entity_id": "T319"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R126",
              "head_entity_id": "T309",
              "tail_entity_id": "T308"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R127",
              "head_entity_id": "T311",
              "tail_entity_id": "T313"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R128",
              "head_entity_id": "T312",
              "tail_entity_id": "T313"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R129",
              "head_entity_id": "T320",
              "tail_entity_id": "T319"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "不过如前所述，速效胰岛素类似物由于起效、达峰和峰效时间更为合理，所以具有更大的治疗优势。",
          "start_idx": 114,
          "end_idx": 158,
          "entities": [
            {
              "entity_id": "T314",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 15
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "目前国内临床上应用的速效胰岛素类似物主要有门冬胰岛素、赖脯胰岛素和谷赖胰岛素，详见见表3。",
          "start_idx": 158,
          "end_idx": 203,
          "entities": [
            {
              "entity_id": "T315",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 18
            },
            {
              "entity_id": "T316",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 26
            },
            {
              "entity_id": "T317",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 32
            },
            {
              "entity_id": "T318",
              "entity": "谷赖胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 38
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "38",
      "paragraph": "临床用法",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床用法",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "39",
      "paragraph": "(1)制剂选择",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)制剂选择",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "40",
      "paragraph": "速效胰岛素类似物常与基础胰岛素联合使用，较少单独三餐前皮下注射，除非患者空腹血糖不高而餐后血糖明显升高，而且必须使用胰岛素治疗，如妊娠糖尿病患者或严重肝肾功能异常的糖尿病患者。此外，胰岛素泵只能采用速效胰岛素类似物或短效人胰岛素；速效胰岛素类似物静脉使用没有优势，故不推荐。三种速效胰岛素类似物尽管在药代动力学和药效学方面有一定的差别，但在对餐后血糖的总体控制、严重低血糖发生率等方面并没有显著差别，三种速效胰岛素类似物在胰岛素泵中的应用优势也类似。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "速效胰岛素类似物常与基础胰岛素联合使用，较少单独三餐前皮下注射，除非患者空腹血糖不高而餐后血糖明显升高，而且必须使用胰岛素治疗，如妊娠糖尿病患者或严重肝肾功能异常的糖尿病患者。此外，胰岛素泵只能采用速效胰岛素类似物或短效人胰岛素；速效胰岛素类似物静脉使用没有优势，故不推荐。三种速效胰岛素类似物尽管在药代动力学和药效学方面有一定的差别，但在对餐后血糖的总体控制、严重低血糖发生率等方面并没有显著差别，三种速效胰岛素类似物在胰岛素泵中的应用优势也类似。",
          "start_idx": 0,
          "end_idx": 225,
          "entities": [
            {
              "entity_id": "T321",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 8
            },
            {
              "entity_id": "T322",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T323",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T324",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 36,
              "end_idx": 40
            },
            {
              "entity_id": "T325",
              "entity": "不高",
              "entity_type": "Test_Value",
              "start_idx": 40,
              "end_idx": 42
            },
            {
              "entity_id": "T326",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 47
            },
            {
              "entity_id": "T327",
              "entity": "明显升高",
              "entity_type": "Test_Value",
              "start_idx": 47,
              "end_idx": 51
            },
            {
              "entity_id": "T328",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 61
            },
            {
              "entity_id": "T329",
              "entity": "妊娠糖尿病",
              "entity_type": "Disease",
              "start_idx": 65,
              "end_idx": 70
            },
            {
              "entity_id": "T330",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 82,
              "end_idx": 85
            },
            {
              "entity_id": "T331",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 99,
              "end_idx": 107
            },
            {
              "entity_id": "T332",
              "entity": "短效人胰岛素",
              "entity_type": "Drug",
              "start_idx": 108,
              "end_idx": 114
            },
            {
              "entity_id": "T333",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 115,
              "end_idx": 123
            },
            {
              "entity_id": "T334",
              "entity": "静脉",
              "entity_type": "Method",
              "start_idx": 123,
              "end_idx": 125
            },
            {
              "entity_id": "T335",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 139,
              "end_idx": 147
            },
            {
              "entity_id": "T336",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 171,
              "end_idx": 175
            },
            {
              "entity_id": "T337",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 183,
              "end_idx": 186
            },
            {
              "entity_id": "T338",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 202,
              "end_idx": 210
            },
            {
              "entity_id": "T339",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 73,
              "end_idx": 75
            },
            {
              "entity_id": "T340",
              "entity": "肝肾功能异常",
              "entity_type": "Disease",
              "start_idx": 75,
              "end_idx": 81
            },
            {
              "entity_id": "T341",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 75,
              "end_idx": 76
            },
            {
              "entity_id": "T342",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 76,
              "end_idx": 77
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R130",
              "head_entity_id": "T323",
              "tail_entity_id": "T321"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R131",
              "head_entity_id": "T323",
              "tail_entity_id": "T322"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R132",
              "head_entity_id": "T328",
              "tail_entity_id": "T329"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R133",
              "head_entity_id": "T328",
              "tail_entity_id": "T330"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R134",
              "head_entity_id": "T334",
              "tail_entity_id": "T333"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R135",
              "head_entity_id": "T337",
              "tail_entity_id": "T335"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R136",
              "head_entity_id": "T337",
              "tail_entity_id": "T338"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R137",
              "head_entity_id": "T341",
              "tail_entity_id": "T340"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R138",
              "head_entity_id": "T342",
              "tail_entity_id": "T340"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "41",
      "paragraph": "(2)使用方法",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)使用方法",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "42",
      "paragraph": "首先要估算初始的胰岛素每日总剂量：在保持相对恒定的饮食及活动量的情况下，需要根据患者的体重、病情、生理需要量等进行估算，一般情况下，1型糖尿病患者可按0.4~0.5单位仟克体重计算，2型糖尿病病患者可按0.5~1.0单位/千克体重计算。然后根据治疗方案的不同计算出餐时胰岛素的用量并合理分配至三餐：采用基础-餐时方案时，餐时胰岛素约占每日总量的40%~60%，再按1/3、1/3、1/3或1/5、2/5、2/5的比例分配至早午晚三餐前注射；采用胰岛素泵治疗时，餐时胰岛素约占每日总量的50%，按1/3、1/3、1/3的比例分配至三餐前大剂量。最后再根据次餐前或睡前血糖的水平调整餐时胰岛素用量：一般先对最高的餐前血糖值进行调整，每3~5天调整1次，每次调整1~2个注射时间点，每次调整胰岛素剂量为1~4个单位，直至血糖达标，调量方法见表4。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "首先要估算初始的胰岛素每日总剂量：在保持相对恒定的饮食及活动量的情况下，需要根据患者的体重、病情、生理需要量等进行估算，一般情况下，1型糖尿病患者可按0.4~0.5单位仟克体重计算，2型糖尿病病患者可按0.5~1.0单位/千克体重计算。然后根据治疗方案的不同计算出餐时胰岛素的用量并合理分配至三餐：采用基础-餐时方案时，餐时胰岛素约占每日总量的40%~60%，再按1/3、1/3、1/3或1/5、2/5、2/5的比例分配至早午晚三餐前注射；采用胰岛素泵治疗时，餐时胰岛素约占每日总量的50%，按1/3、1/3、1/3的比例分配至三餐前大剂量。",
          "start_idx": 0,
          "end_idx": 271,
          "entities": [
            {
              "entity_id": "T343",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T344",
              "entity": "1型糖尿病",
              "entity_type": "Disease",
              "start_idx": 66,
              "end_idx": 71
            },
            {
              "entity_id": "T345",
              "entity": "1型",
              "entity_type": "Class",
              "start_idx": 66,
              "end_idx": 68
            },
            {
              "entity_id": "T346",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 91,
              "end_idx": 96
            },
            {
              "entity_id": "T347",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 91,
              "end_idx": 93
            },
            {
              "entity_id": "T348",
              "entity": "0.4~0.5单位仟克体重",
              "entity_type": "Amount",
              "start_idx": 75,
              "end_idx": 88
            },
            {
              "entity_id": "T349",
              "entity": "0.5~1.0单位/千克",
              "entity_type": "Amount",
              "start_idx": 101,
              "end_idx": 113
            },
            {
              "entity_id": "T350",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 134,
              "end_idx": 137
            },
            {
              "entity_id": "T351",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 162,
              "end_idx": 165
            },
            {
              "entity_id": "T352",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 217,
              "end_idx": 219
            },
            {
              "entity_id": "T353",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 232,
              "end_idx": 235
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R139",
              "head_entity_id": "T348",
              "tail_entity_id": "T343"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R140",
              "head_entity_id": "T349",
              "tail_entity_id": "T343"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R141",
              "head_entity_id": "T345",
              "tail_entity_id": "T344"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R142",
              "head_entity_id": "T347",
              "tail_entity_id": "T346"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R143",
              "head_entity_id": "T352",
              "tail_entity_id": "T350"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R144",
              "head_entity_id": "T352",
              "tail_entity_id": "T351"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "最后再根据次餐前或睡前血糖的水平调整餐时胰岛素用量：一般先对最高的餐前血糖值进行调整，每3~5天调整1次，每次调整1~2个注射时间点，每次调整胰岛素剂量为1~4个单位，直至血糖达标，调量方法见表4。",
          "start_idx": 271,
          "end_idx": 370,
          "entities": [
            {
              "entity_id": "T354",
              "entity": "睡前血糖",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 13
            },
            {
              "entity_id": "T355",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 23
            },
            {
              "entity_id": "T356",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 33,
              "end_idx": 37
            },
            {
              "entity_id": "T357",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 71,
              "end_idx": 74
            },
            {
              "entity_id": "T358",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 86,
              "end_idx": 88
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "43",
      "paragraph": "(3)特殊情况",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)特殊情况",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "44",
      "paragraph": "①妊娠期：目前，CFDA仅批准门冬胰岛素在妊娠期间使用。研究显示，相比于短效人胰岛素，门冬胰岛素在改善母婴预后方面更具优势。②儿童和青少年：门冬胰岛素已被CFDA批准用于2岁以上儿童及青少年糖尿病患者；我国的《儿童及青少年糖尿病患者的胰岛素治疗指南》建议赖脯胰岛素的使用年龄为12 岁以上。③肝、肾功能不全：糖尿病合并肾功能不全患者的胰岛素治疗应优先选择短效胰岛素威速效胰岛素类似物。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①妊娠期：目前，CFDA仅批准门冬胰岛素在妊娠期间使用。",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T359",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 20
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "研究显示，相比于短效人胰岛素，门冬胰岛素在改善母婴预后方面更具优势。②儿童和青少年：门冬胰岛素已被CFDA批准用于2岁以上儿童及青少年糖尿病患者；我国的《儿童及青少年糖尿病患者的胰岛素治疗指南》建议赖脯胰岛素的使用年龄为12 岁以上。③肝、肾功能不全：糖尿病合并肾功能不全患者的胰岛素治疗应优先选择短效胰岛素威速效胰岛素类似物。",
          "start_idx": 28,
          "end_idx": 192,
          "entities": [
            {
              "entity_id": "T360",
              "entity": "短效人胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 14
            },
            {
              "entity_id": "T361",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 20
            },
            {
              "entity_id": "T362",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 42,
              "end_idx": 47
            },
            {
              "entity_id": "T363",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 70
            },
            {
              "entity_id": "T364",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 83,
              "end_idx": 86
            },
            {
              "entity_id": "T365",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 89,
              "end_idx": 92
            },
            {
              "entity_id": "T366",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 99,
              "end_idx": 104
            },
            {
              "entity_id": "T367",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 120,
              "end_idx": 125
            },
            {
              "entity_id": "T368",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 120,
              "end_idx": 121
            },
            {
              "entity_id": "T369",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 126,
              "end_idx": 129
            },
            {
              "entity_id": "T370",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 131,
              "end_idx": 136
            },
            {
              "entity_id": "T371",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 139,
              "end_idx": 142
            },
            {
              "entity_id": "T372",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 149,
              "end_idx": 154
            },
            {
              "entity_id": "T373",
              "entity": "速效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 155,
              "end_idx": 163
            },
            {
              "entity_id": "T374",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 131,
              "end_idx": 132
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R145",
              "head_entity_id": "T362",
              "tail_entity_id": "T363"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R146",
              "head_entity_id": "T366",
              "tail_entity_id": "T364"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R147",
              "head_entity_id": "T365",
              "tail_entity_id": "T364"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R148",
              "head_entity_id": "T368",
              "tail_entity_id": "T367"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R149",
              "head_entity_id": "T371",
              "tail_entity_id": "T369"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R150",
              "head_entity_id": "T372",
              "tail_entity_id": "T369"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R151",
              "head_entity_id": "T373",
              "tail_entity_id": "T369"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R152",
              "head_entity_id": "T374",
              "tail_entity_id": "T370"
            }
          ]
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 192,
          "end_idx": 193,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "45",
      "paragraph": "基础胰岛素： 《成人2型糖尿病基础胰岛素临床应用中国专家指导建议》 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基础胰岛素： 《成人2型糖尿病基础胰岛素临床应用中国专家指导建议》 ",
          "start_idx": 0,
          "end_idx": 34,
          "entities": [
            {
              "entity_id": "T375",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 5
            },
            {
              "entity_id": "T376",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T377",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 10,
              "end_idx": 12
            },
            {
              "entity_id": "T378",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R153",
              "head_entity_id": "T377",
              "tail_entity_id": "T376"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R154",
              "head_entity_id": "T378",
              "tail_entity_id": "T376"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "46",
      "paragraph": "基础胰岛素是胰岛素治疗方案中常用的胰岛素类型，具有低血糖风险低，使用简单方便等优点，既可与口服降糖药物联用作为起始方案，又可与餐时胰岛素组成强化治疗方案。然而，临床研究显示，中国2型糖尿病患者起始基础胰岛素治疗较晚，起始剂量偏低且在起始治疗后剂量调整不足，是导致起始胰岛素治疗后血糖控制不满意的重要原因。为此，国内多位内分泌学专家在2017年初联合发布了《成人2型糖尿病基础胰岛素临床应用中国专家指导建议》，以规范基础胰岛素在临床上的合理使用。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基础胰岛素是胰岛素治疗方案中常用的胰岛素类型，具有低血糖风险低，使用简单方便等优点，既可与口服降糖药物联用作为起始方案，又可与餐时胰岛素组成强化治疗方案。然而，临床研究显示，中国2型糖尿病患者起始基础胰岛素治疗较晚，起始剂量偏低且在起始治疗后剂量调整不足，是导致起始胰岛素治疗后血糖控制不满意的重要原因。为此，国内多位内分泌学专家在2017年初联合发布了《成人2型糖尿病基础胰岛素临床应用中国专家指导建议》，以规范基础胰岛素在临床上的合理使用。",
          "start_idx": 0,
          "end_idx": 222,
          "entities": [
            {
              "entity_id": "T379",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 5
            },
            {
              "entity_id": "T380",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T381",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T382",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 25,
              "end_idx": 28
            },
            {
              "entity_id": "T383",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 65,
              "end_idx": 68
            },
            {
              "entity_id": "T384",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 89,
              "end_idx": 94
            },
            {
              "entity_id": "T385",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 89,
              "end_idx": 91
            },
            {
              "entity_id": "T386",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 100,
              "end_idx": 103
            },
            {
              "entity_id": "T387",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 133,
              "end_idx": 136
            },
            {
              "entity_id": "T388",
              "entity": "血糖控制",
              "entity_type": "Test_items",
              "start_idx": 139,
              "end_idx": 143
            },
            {
              "entity_id": "T389",
              "entity": "不满意",
              "entity_type": "Test_Value",
              "start_idx": 143,
              "end_idx": 146
            },
            {
              "entity_id": "T390",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 180,
              "end_idx": 185
            },
            {
              "entity_id": "T391",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 180,
              "end_idx": 182
            },
            {
              "entity_id": "T392",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 187,
              "end_idx": 190
            },
            {
              "entity_id": "T393",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 209,
              "end_idx": 212
            },
            {
              "entity_id": "T394",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 45,
              "end_idx": 47
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R155",
              "head_entity_id": "T385",
              "tail_entity_id": "T384"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R156",
              "head_entity_id": "T386",
              "tail_entity_id": "T384"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R157",
              "head_entity_id": "T388",
              "tail_entity_id": "T384"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R158",
              "head_entity_id": "T391",
              "tail_entity_id": "T390"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R159",
              "head_entity_id": "T392",
              "tail_entity_id": "T390"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R160",
              "head_entity_id": "T393",
              "tail_entity_id": "T390"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 222,
          "end_idx": 223,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "47",
      "paragraph": "作用特点 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "作用特点 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "48",
      "paragraph": "目前，国内临床使用的基础胰岛素主要包括中效胰岛素(NPH，中性鱼精蛋白锌胰岛素) 、长效胰岛素(PZI，精蛋白锌胰岛素) 和长效人胰岛素类似物 (甘精胰岛素，地特胰岛素等) ，详见表5。NPH具有明显峰值，变异性较大，低血糖发生风险相对高，但价格较低。长效胰岛素目前临床上已经很少使用。长效人胰岛素类似物平稳无峰，能更好地模拟生理性胰岛素分泌，减少低血糖风险，但价格较高。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前，国内临床使用的基础胰岛素主要包括中效胰岛素(NPH，中性鱼精蛋白锌胰岛素) 、长效胰岛素(PZI，精蛋白锌胰岛素) 和长效人胰岛素类似物 (甘精胰岛素，地特胰岛素等) ，详见表5。NPH具有明显峰值，变异性较大，低血糖发生风险相对高，但价格较低。",
          "start_idx": 0,
          "end_idx": 126,
          "entities": [
            {
              "entity_id": "T395",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T396",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 24
            },
            {
              "entity_id": "T397",
              "entity": "NPH",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 28
            },
            {
              "entity_id": "T398",
              "entity": "中性鱼精蛋白锌胰岛素",
              "entity_type": "Drug",
              "start_idx": 29,
              "end_idx": 39
            },
            {
              "entity_id": "T399",
              "entity": "长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 42,
              "end_idx": 47
            },
            {
              "entity_id": "T400",
              "entity": "精蛋白锌胰岛素",
              "entity_type": "Drug",
              "start_idx": 52,
              "end_idx": 59
            },
            {
              "entity_id": "T401",
              "entity": "PZI",
              "entity_type": "Drug",
              "start_idx": 48,
              "end_idx": 51
            },
            {
              "entity_id": "T402",
              "entity": "长效人胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 62,
              "end_idx": 71
            },
            {
              "entity_id": "T403",
              "entity": "甘精胰岛素",
              "entity_type": "Drug",
              "start_idx": 73,
              "end_idx": 78
            },
            {
              "entity_id": "T404",
              "entity": "地特胰岛素",
              "entity_type": "Drug",
              "start_idx": 79,
              "end_idx": 84
            },
            {
              "entity_id": "T405",
              "entity": "NPH",
              "entity_type": "Drug",
              "start_idx": 93,
              "end_idx": 96
            },
            {
              "entity_id": "T408",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 109,
              "end_idx": 112
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R161",
              "head_entity_id": "T408",
              "tail_entity_id": "T405"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "长效胰岛素目前临床上已经很少使用。",
          "start_idx": 126,
          "end_idx": 143,
          "entities": [
            {
              "entity_id": "T406",
              "entity": "长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "长效人胰岛素类似物平稳无峰，能更好地模拟生理性胰岛素分泌，减少低血糖风险，但价格较高。",
          "start_idx": 143,
          "end_idx": 186,
          "entities": [
            {
              "entity_id": "T407",
              "entity": "效人胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 9
            },
            {
              "entity_id": "T409",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 31,
              "end_idx": 34
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 186,
          "end_idx": 187,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "49",
      "paragraph": "临床用法 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床用法 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "50",
      "paragraph": "(1)适用人群 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)适用人群 ",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "51",
      "paragraph": "①口服降糖药联合基础胰岛素方案：高血糖 (FPG>11.1毫摩尔/升，或HbA1c>9%) 伴明显高血糖症状的新诊2型糖尿病患者；1~2种口服降糖药 (超重或肥胖患者1~3种口服降糖药)规范治疗3个月以上血糖控制仍未达标者；正在接受预混胰岛素治疗(低于50单位/天)的患者血糖控制不佳，频繁发作低血糖者，或对每日2次预混胰岛素注射依从性差者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①口服降糖药联合基础胰岛素方案：高血糖 (FPG>11.1毫摩尔/升，或HbA1c>9%) 伴明显高血糖症状的新诊2型糖尿病患者；1~2种口服降糖药 (超重或肥胖患者1~3种口服降糖药)规范治疗3个月以上血糖控制仍未达标者；正在接受预混胰岛素治疗(低于50单位/天)的患者血糖控制不佳，频繁发作低血糖者，或对每日2次预混胰岛素注射依从性差者。",
          "start_idx": 0,
          "end_idx": 171,
          "entities": [
            {
              "entity_id": "T410",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 19
            },
            {
              "entity_id": "T411",
              "entity": ">11.1毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 24,
              "end_idx": 34
            },
            {
              "entity_id": "T412",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 36,
              "end_idx": 41
            },
            {
              "entity_id": "T413",
              "entity": ">9%",
              "entity_type": "Test_Value",
              "start_idx": 41,
              "end_idx": 44
            },
            {
              "entity_id": "T414",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 52
            },
            {
              "entity_id": "T415",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 62
            },
            {
              "entity_id": "T416",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 57,
              "end_idx": 59
            },
            {
              "entity_id": "T417",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 76,
              "end_idx": 78
            },
            {
              "entity_id": "T418",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 79,
              "end_idx": 81
            },
            {
              "entity_id": "T419",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 102,
              "end_idx": 104
            },
            {
              "entity_id": "T420",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 116,
              "end_idx": 121
            },
            {
              "entity_id": "T421",
              "entity": "低于50单位/天",
              "entity_type": "Amount",
              "start_idx": 124,
              "end_idx": 132
            },
            {
              "entity_id": "T422",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 136,
              "end_idx": 138
            },
            {
              "entity_id": "T423",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 138,
              "end_idx": 142
            },
            {
              "entity_id": "T424",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 147,
              "end_idx": 150
            },
            {
              "entity_id": "T425",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 158,
              "end_idx": 163
            },
            {
              "entity_id": "T426",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 154,
              "end_idx": 158
            },
            {
              "entity_id": "T427",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 163,
              "end_idx": 165
            },
            {
              "entity_id": "T428",
              "entity": "未达标",
              "entity_type": "Test_Value",
              "start_idx": 107,
              "end_idx": 110
            },
            {
              "entity_id": "T429",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T430",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 13
            },
            {
              "entity_id": "T431",
              "entity": "FPG",
              "entity_type": "Test_items",
              "start_idx": 21,
              "end_idx": 24
            },
            {
              "entity_id": "T432",
              "entity": "明显",
              "entity_type": "Level",
              "start_idx": 47,
              "end_idx": 49
            },
            {
              "entity_id": "T433",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 87,
              "end_idx": 89
            },
            {
              "entity_id": "T434",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 69,
              "end_idx": 71
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R162",
              "head_entity_id": "T431",
              "tail_entity_id": "T410"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R163",
              "head_entity_id": "T412",
              "tail_entity_id": "T410"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R164",
              "head_entity_id": "T416",
              "tail_entity_id": "T415"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R165",
              "head_entity_id": "T421",
              "tail_entity_id": "T420"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R166",
              "head_entity_id": "T427",
              "tail_entity_id": "T425"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R167",
              "head_entity_id": "T426",
              "tail_entity_id": "T425"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 171,
          "end_idx": 172,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "52",
      "paragraph": "②基础胰岛素联合餐时胰岛素方案：口服降糖药联合基础胰岛素治疗后，空腹血糖达标，HbA1c仍不达标者，或使用较大剂量基础胰岛素后[如0.6单位/ (千克·天)]，血糖仍不达标者；使用多次预混胰岛素治疗，血糖控制不佳者或反复发作低血糖者；需短时间内纠正高血糖的糖尿病患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②基础胰岛素联合餐时胰岛素方案：口服降糖药联合基础胰岛素治疗后，空腹血糖达标，HbA1c仍不达标者，或使用较大剂量基础胰岛素后[如0.6单位/ (千克·天)]，血糖仍不达标者；使用多次预混胰岛素治疗，血糖控制不佳者或反复发作低血糖者；需短时间内纠正高血糖的糖尿病患者。",
          "start_idx": 0,
          "end_idx": 134,
          "entities": [
            {
              "entity_id": "T435",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 6
            },
            {
              "entity_id": "T436",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 13
            },
            {
              "entity_id": "T437",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 28
            },
            {
              "entity_id": "T438",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 32,
              "end_idx": 36
            },
            {
              "entity_id": "T439",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 39,
              "end_idx": 44
            },
            {
              "entity_id": "T440",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 62
            },
            {
              "entity_id": "T441",
              "entity": "0.6单位/ (千克·天",
              "entity_type": "Amount",
              "start_idx": 65,
              "end_idx": 77
            },
            {
              "entity_id": "T442",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 80,
              "end_idx": 82
            },
            {
              "entity_id": "T443",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 92,
              "end_idx": 97
            },
            {
              "entity_id": "T444",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 102
            },
            {
              "entity_id": "T445",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 102,
              "end_idx": 106
            },
            {
              "entity_id": "T446",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 112,
              "end_idx": 115
            },
            {
              "entity_id": "T447",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 124,
              "end_idx": 127
            },
            {
              "entity_id": "T448",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 128,
              "end_idx": 131
            },
            {
              "entity_id": "T449",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 45,
              "end_idx": 48
            },
            {
              "entity_id": "T450",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 83,
              "end_idx": 86
            },
            {
              "entity_id": "T451",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 16,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R168",
              "head_entity_id": "T441",
              "tail_entity_id": "T440"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 134,
          "end_idx": 135,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "53",
      "paragraph": "(2)使用方法 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)使用方法 ",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "54",
      "paragraph": "①口服降糖药联合基础胰岛素方案：血糖明显增高伴有明显高血糖症状的新诊断糖尿病患者或口服降糖药治疗血糖控制不佳的患者起始基础胰岛素时，可根据体重计算每日起始剂量，通常为0.1~0.3单位/千克体重，肥胖患者或HbA1c>8.0%时，可考虑0.2~0.3单位/千克体重起始。从预混缺岛素治疗转换为基础胰岛素时，可依据血糖水平，按照原预混胰岛素总剂量的60%-80%起始基础胰岛素；如HbA1c≦8.0%，基础胰岛素起始剂量=原预混胰岛素总量x 0.6，HbA1c>8%时，推荐起始剂量=原预混胰岛素总量x0.8。口服药种类和剂量根据患者个体情况酌情选择和调整。此后，根据空腹血糖水平，在避免低血糖的情况下及时调整胰岛素剂量。多数患者长效胰岛素类似物每日剂量达到约0.5单位/千克体重前，可通过继续调整剂量控制血糖，而无需调整治疗方案。在血糖未达到设定的血糖目标值前，建议患者在医生指导下，根据空腹血糖，每周调整2~6单位直至空腹血糖达标；对于能进行血糖测、感知低血糖、进行自我管理的患者，医生可指导其进行简使易行的自我胰岛素剂量调整，每3天调整2~3单位直至空腹血糖达标，详见表6。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①口服降糖药联合基础胰岛素方案：血糖明显增高伴有明显高血糖症状的新诊断糖尿病患者或口服降糖药治疗血糖控制不佳的患者起始基础胰岛素时，可根据体重计算每日起始剂量，通常为0.1~0.3单位/千克体重，肥胖患者或HbA1c>8.0%时，可考虑0.2~0.3单位/千克体重起始。从预混缺岛素治疗转换为基础胰岛素时，可依据血糖水平，按照原预混胰岛素总剂量的60%-80%起始基础胰岛素；如HbA1c≦8.0%，基础胰岛素起始剂量=原预混胰岛素总量x 0.6，HbA1c>8%时，推荐起始剂量=原预混胰岛素总量x0.8。口服药种类和剂量根据患者个体情况酌情选择和调整。此后，根据空腹血糖水平，在避免低血糖的情况下及时调整胰岛素剂量。多数患者长效胰岛素类似物每日剂量达到约0.5单位/千克体重前，可通过继续调整剂量控制血糖，而无需调整治疗方案。",
          "start_idx": 0,
          "end_idx": 365,
          "entities": [
            {
              "entity_id": "T452",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 13
            },
            {
              "entity_id": "T453",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 16,
              "end_idx": 18
            },
            {
              "entity_id": "T454",
              "entity": "明显增高",
              "entity_type": "Test_Value",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T455",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 29
            },
            {
              "entity_id": "T456",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 38
            },
            {
              "entity_id": "T457",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 48,
              "end_idx": 50
            },
            {
              "entity_id": "T458",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 50,
              "end_idx": 54
            },
            {
              "entity_id": "T459",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 61,
              "end_idx": 64
            },
            {
              "entity_id": "T460",
              "entity": "0.1~0.3单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 83,
              "end_idx": 97
            },
            {
              "entity_id": "T461",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 98,
              "end_idx": 100
            },
            {
              "entity_id": "T462",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 103,
              "end_idx": 108
            },
            {
              "entity_id": "T463",
              "entity": ">8.0%",
              "entity_type": "Test_Value",
              "start_idx": 108,
              "end_idx": 113
            },
            {
              "entity_id": "T464",
              "entity": "0.2~0.3单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 118,
              "end_idx": 132
            },
            {
              "entity_id": "T465",
              "entity": "预混缺岛素",
              "entity_type": "Drug",
              "start_idx": 136,
              "end_idx": 141
            },
            {
              "entity_id": "T466",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 148,
              "end_idx": 151
            },
            {
              "entity_id": "T467",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 156,
              "end_idx": 158
            },
            {
              "entity_id": "T468",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 164,
              "end_idx": 169
            },
            {
              "entity_id": "T469",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 184,
              "end_idx": 187
            },
            {
              "entity_id": "T470",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 189,
              "end_idx": 194
            },
            {
              "entity_id": "T471",
              "entity": "≦8.0%",
              "entity_type": "Test_Value",
              "start_idx": 194,
              "end_idx": 199
            },
            {
              "entity_id": "T472",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 202,
              "end_idx": 205
            },
            {
              "entity_id": "T473",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 211,
              "end_idx": 216
            },
            {
              "entity_id": "T474",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 224,
              "end_idx": 229
            },
            {
              "entity_id": "T475",
              "entity": ">8%",
              "entity_type": "Test_Value",
              "start_idx": 229,
              "end_idx": 232
            },
            {
              "entity_id": "T476",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 242,
              "end_idx": 247
            },
            {
              "entity_id": "T477",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 283,
              "end_idx": 287
            },
            {
              "entity_id": "T478",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 293,
              "end_idx": 296
            },
            {
              "entity_id": "T479",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 304,
              "end_idx": 307
            },
            {
              "entity_id": "T480",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 314,
              "end_idx": 322
            },
            {
              "entity_id": "T481",
              "entity": "0.5单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 329,
              "end_idx": 339
            },
            {
              "entity_id": "T482",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 352,
              "end_idx": 354
            },
            {
              "entity_id": "T491",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T492",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 41,
              "end_idx": 43
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R169",
              "head_entity_id": "T453",
              "tail_entity_id": "T455"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R170",
              "head_entity_id": "T453",
              "tail_entity_id": "T456"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R171",
              "head_entity_id": "T460",
              "tail_entity_id": "T459"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R172",
              "head_entity_id": "T464",
              "tail_entity_id": "T459"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R173",
              "head_entity_id": "T481",
              "tail_entity_id": "T480"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "在血糖未达到设定的血糖目标值前，建议患者在医生指导下，根据空腹血糖，每周调整2~6单位直至空腹血糖达标；对于能进行血糖测、感知低血糖、进行自我管理的患者，医生可指导其进行简使易行的自我胰岛素剂量调整，每3天调整2~3单位直至空腹血糖达标，详见表6。",
          "start_idx": 365,
          "end_idx": 489,
          "entities": [
            {
              "entity_id": "T483",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T484",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 11
            },
            {
              "entity_id": "T485",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 29,
              "end_idx": 33
            },
            {
              "entity_id": "T486",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 45,
              "end_idx": 49
            },
            {
              "entity_id": "T487",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 59
            },
            {
              "entity_id": "T488",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 63,
              "end_idx": 66
            },
            {
              "entity_id": "T489",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 92,
              "end_idx": 95
            },
            {
              "entity_id": "T490",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 112,
              "end_idx": 116
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 489,
          "end_idx": 490,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "55",
      "paragraph": "②基础胰岛素联合餐时胰岛素方案：对于口服降糖药联合基础胰岛素治疗的患者，基础胰岛素可维持原剂量，开始时可在主餐/早餐前给予餐时胰岛素4-6单位，然后逐步增加餐时胰岛素，根据下一餐前血糖值，每周调整1~2次餐时胰岛素剂量，每次调整1-2单位或10%~15%直至达到下次餐前血糖目标，根据每3~6个月的HbA1c结果，如需要可逐渐增加至每日2~3次餐时胰岛素注射。对于之前使用预混胰岛素的患者，可按照原先预混胰岛素剂量的40%~50% 作为基础胰岛素，剩余量作为餐时胰岛素，三餐平均分配；对于需短时间内纠正高血糖的患者，可根据0.3~0.5单位/千克体重来估算起始胰岛素总量，其中，50%为基础胰岛素，50%为餐时胰岛素，三餐平均分配。采用基础+三餐前胰岛素治疗方案时，如果血糖水平整体偏高，可先调整基础胰岛素剂量，对于需尽快解除高血糖状态的情况，则可同时调整基础和餐时的剂量。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②基础胰岛素联合餐时胰岛素方案：对于口服降糖药联合基础胰岛素治疗的患者，基础胰岛素可维持原剂量，开始时可在主餐/早餐前给予餐时胰岛素4-6单位，然后逐步增加餐时胰岛素，根据下一餐前血糖值，每周调整1~2次餐时胰岛素剂量，每次调整1-2单位或10%~15%直至达到下次餐前血糖目标，根据每3~6个月的HbA1c结果，如需要可逐渐增加至每日2~3次餐时胰岛素注射。对于之前使用预混胰岛素的患者，可按照原先预混胰岛素剂量的40%~50% 作为基础胰岛素，剩余量作为餐时胰岛素，三餐平均分配；对于需短时间内纠正高血糖的患者，可根据0.3~0.5单位/千克体重来估算起始胰岛素总量，其中，50%为基础胰岛素，50%为餐时胰岛素，三餐平均分配。",
          "start_idx": 0,
          "end_idx": 316,
          "entities": [
            {
              "entity_id": "T493",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 6
            },
            {
              "entity_id": "T494",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 30
            },
            {
              "entity_id": "T495",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 38,
              "end_idx": 41
            },
            {
              "entity_id": "T496",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T497",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 61,
              "end_idx": 66
            },
            {
              "entity_id": "T498",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 78,
              "end_idx": 83
            },
            {
              "entity_id": "T499",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 88,
              "end_idx": 92
            },
            {
              "entity_id": "T500",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 102,
              "end_idx": 107
            },
            {
              "entity_id": "T501",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 133,
              "end_idx": 137
            },
            {
              "entity_id": "T502",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 149,
              "end_idx": 154
            },
            {
              "entity_id": "T503",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 172,
              "end_idx": 177
            },
            {
              "entity_id": "T504",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 177,
              "end_idx": 179
            },
            {
              "entity_id": "T505",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 186,
              "end_idx": 191
            },
            {
              "entity_id": "T506",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 200,
              "end_idx": 205
            },
            {
              "entity_id": "T507",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 220,
              "end_idx": 223
            },
            {
              "entity_id": "T508",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 229,
              "end_idx": 234
            },
            {
              "entity_id": "T509",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 251,
              "end_idx": 254
            },
            {
              "entity_id": "T510",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 280,
              "end_idx": 283
            },
            {
              "entity_id": "T511",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 295,
              "end_idx": 298
            },
            {
              "entity_id": "T512",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 303,
              "end_idx": 308
            },
            {
              "entity_id": "T518",
              "entity": "0.3~0.5单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 261,
              "end_idx": 275
            },
            {
              "entity_id": "T519",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 18,
              "end_idx": 20
            },
            {
              "entity_id": "T520",
              "entity": "每日2~3次",
              "entity_type": "Frequency",
              "start_idx": 166,
              "end_idx": 172
            },
            {
              "entity_id": "T521",
              "entity": "4-6单位",
              "entity_type": "Amount",
              "start_idx": 66,
              "end_idx": 71
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R174",
              "head_entity_id": "T521",
              "tail_entity_id": "T497"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R175",
              "head_entity_id": "T504",
              "tail_entity_id": "T503"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R176",
              "head_entity_id": "T520",
              "tail_entity_id": "T503"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R177",
              "head_entity_id": "T510",
              "tail_entity_id": "T509"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R178",
              "head_entity_id": "T518",
              "tail_entity_id": "T510"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "采用基础+三餐前胰岛素治疗方案时，如果血糖水平整体偏高，可先调整基础胰岛素剂量，对于需尽快解除高血糖状态的情况，则可同时调整基础和餐时的剂量。",
          "start_idx": 316,
          "end_idx": 387,
          "entities": [
            {
              "entity_id": "T513",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T514",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 21
            },
            {
              "entity_id": "T515",
              "entity": "整体偏高",
              "entity_type": "Test_Value",
              "start_idx": 23,
              "end_idx": 27
            },
            {
              "entity_id": "T516",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 34,
              "end_idx": 37
            },
            {
              "entity_id": "T517",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 47,
              "end_idx": 50
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 387,
          "end_idx": 388,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "56",
      "paragraph": "条件允许时，在起始胰岛素治疗的早期可通过住院密切监测血糖来每天调整胰岛素剂量：根据空腹血糖，调整基础胰岛素剂量1~4单位或10%~20%；根据下一餐前血糖值，调整餐时胰岛素剂量1-2单位或10%。如果出现空腹或夜间低血糖(<3.9毫摩尔/升)或低血糖症状，则应减少基础胰岛素和/或晚餐前的餐时胰岛素剂量10%~20%；如果日间两餐间出低血糖，则减少上一餐的餐时胰岛素剂量10%~20%；如出现需他人协助的严重低血糖或随机血糖<2.2毫摩尔/升，则减少20%~40%胰岛素剂量。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "条件允许时，在起始胰岛素治疗的早期可通过住院密切监测血糖来每天调整胰岛素剂量：根据空腹血糖，调整基础胰岛素剂量1~4单位或10%~20%；根据下一餐前血糖值，调整餐时胰岛素剂量1-2单位或10%。如果出现空腹或夜间低血糖(<3.9毫摩尔/升)或低血糖症状，则应减少基础胰岛素和/或晚餐前的餐时胰岛素剂量10%~20%；如果日间两餐间出低血糖，则减少上一餐的餐时胰岛素剂量10%~20%；如出现需他人协助的严重低血糖或随机血糖<2.2毫摩尔/升，则减少20%~40%胰岛素剂量。",
          "start_idx": 0,
          "end_idx": 238,
          "entities": [
            {
              "entity_id": "T522",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 12
            },
            {
              "entity_id": "T523",
              "entity": "监测血糖",
              "entity_type": "Test_items",
              "start_idx": 24,
              "end_idx": 28
            },
            {
              "entity_id": "T524",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 36
            },
            {
              "entity_id": "T525",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 41,
              "end_idx": 45
            },
            {
              "entity_id": "T526",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 73,
              "end_idx": 77
            },
            {
              "entity_id": "T527",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 50,
              "end_idx": 53
            },
            {
              "entity_id": "T528",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 81,
              "end_idx": 86
            },
            {
              "entity_id": "T529",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 108,
              "end_idx": 110
            },
            {
              "entity_id": "T530",
              "entity": "<3.9毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 111,
              "end_idx": 120
            },
            {
              "entity_id": "T531",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 122,
              "end_idx": 125
            },
            {
              "entity_id": "T532",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 134,
              "end_idx": 137
            },
            {
              "entity_id": "T533",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 144,
              "end_idx": 149
            },
            {
              "entity_id": "T534",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 167,
              "end_idx": 170
            },
            {
              "entity_id": "T535",
              "entity": "餐时胰岛素",
              "entity_type": "Drug",
              "start_idx": 178,
              "end_idx": 183
            },
            {
              "entity_id": "T536",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 204,
              "end_idx": 207
            },
            {
              "entity_id": "T537",
              "entity": "随机血糖",
              "entity_type": "Test_items",
              "start_idx": 208,
              "end_idx": 212
            },
            {
              "entity_id": "T538",
              "entity": "<2.2毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 212,
              "end_idx": 221
            },
            {
              "entity_id": "T539",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 232,
              "end_idx": 235
            },
            {
              "entity_id": "T540",
              "entity": "1~4单位",
              "entity_type": "Amount",
              "start_idx": 55,
              "end_idx": 60
            },
            {
              "entity_id": "T541",
              "entity": "1-2单位",
              "entity_type": "Amount",
              "start_idx": 88,
              "end_idx": 93
            }
          ],
          "relations": [
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R179",
              "head_entity_id": "T540",
              "tail_entity_id": "T527"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R180",
              "head_entity_id": "T541",
              "tail_entity_id": "T528"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R181",
              "head_entity_id": "T531",
              "tail_entity_id": "T532"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R182",
              "head_entity_id": "T534",
              "tail_entity_id": "T535"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R183",
              "head_entity_id": "T536",
              "tail_entity_id": "T539"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 238,
          "end_idx": 239,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "57",
      "paragraph": "(3)特殊情况 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)特殊情况 ",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "58",
      "paragraph": "①老年患者：老年糖尿病患者常合并多种疾病，器官功能减退，且低血糖感知性弱、耐受性差，认知能力、自我管理能力下降。因此，老年糖尿病患者血糖控制目标一般较为宽松，在选择降糖药物时，除了控糖达标以预防和减少并发症，更应当考虑其肝、肾功能及合并用药的相互作用，减少低血糖发生。临床上常采用口服降糖药治疗，需胰岛素治疗时通常推荐使用基础胰岛素，尤其是低血糖风险较低的长效胰岛素类似物。除新诊断伴严重高血糖症状及某些特殊情况外，不推荐多次胰岛素注射的方案。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①老年患者：老年糖尿病患者常合并多种疾病，器官功能减退，且低血糖感知性弱、耐受性差，认知能力、自我管理能力下降。因此，老年糖尿病患者血糖控制目标一般较为宽松，在选择降糖药物时，除了控糖达标以预防和减少并发症，更应当考虑其肝、肾功能及合并用药的相互作用，减少低血糖发生。临床上常采用口服降糖药治疗，需胰岛素治疗时通常推荐使用基础胰岛素，尤其是低血糖风险较低的长效胰岛素类似物。除新诊断伴严重高血糖症状及某些特殊情况外，不推荐多次胰岛素注射的方案。",
          "start_idx": 0,
          "end_idx": 222,
          "entities": [
            {
              "entity_id": "T542",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T543",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 29,
              "end_idx": 32
            },
            {
              "entity_id": "T544",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 64
            },
            {
              "entity_id": "T545",
              "entity": "血糖控制",
              "entity_type": "Test_items",
              "start_idx": 66,
              "end_idx": 70
            },
            {
              "entity_id": "T546",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 128,
              "end_idx": 131
            },
            {
              "entity_id": "T547",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 149,
              "end_idx": 152
            },
            {
              "entity_id": "T548",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 163,
              "end_idx": 166
            },
            {
              "entity_id": "T549",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 170,
              "end_idx": 173
            },
            {
              "entity_id": "T550",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 178,
              "end_idx": 186
            },
            {
              "entity_id": "T551",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 194,
              "end_idx": 197
            },
            {
              "entity_id": "T552",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 213,
              "end_idx": 216
            },
            {
              "entity_id": "T553",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 216,
              "end_idx": 218
            },
            {
              "entity_id": "T554",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 140,
              "end_idx": 142
            },
            {
              "entity_id": "T555",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 192,
              "end_idx": 194
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R184",
              "head_entity_id": "T553",
              "tail_entity_id": "T552"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 222,
          "end_idx": 223,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "59",
      "paragraph": "②妊娠期：无论是妊娠期糖尿病还是糖尿病合并妊娠，当通过饮食治疗血糖不能得到满意控制时，均需起始胰岛素治疗。由于人胰岛素不通过胎盘屏障，因此NPH在妊娠期间使用不受限制。但由于长效胰岛素类似物在妊娠妇女中临床证据有限，临床医生需充分考虑获益及潜在风险后确定是否使用。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②妊娠期：无论是妊娠期糖尿病还是糖尿病合并妊娠，当通过饮食治疗血糖不能得到满意控制时，均需起始胰岛素治疗。由于人胰岛素不通过胎盘屏障，因此NPH在妊娠期间使用不受限制。",
          "start_idx": 0,
          "end_idx": 84,
          "entities": [
            {
              "entity_id": "T556",
              "entity": "妊娠期糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 14
            },
            {
              "entity_id": "T557",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 19
            },
            {
              "entity_id": "T558",
              "entity": "饮食治疗",
              "entity_type": "Treatment",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T559",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T560",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 47,
              "end_idx": 50
            },
            {
              "entity_id": "T561",
              "entity": "人胰岛素",
              "entity_type": "Drug",
              "start_idx": 55,
              "end_idx": 59
            },
            {
              "entity_id": "T562",
              "entity": "NPH",
              "entity_type": "Drug",
              "start_idx": 69,
              "end_idx": 72
            }
          ],
          "relations": [
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R185",
              "head_entity_id": "T558",
              "tail_entity_id": "T556"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R186",
              "head_entity_id": "T559",
              "tail_entity_id": "T556"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "但由于长效胰岛素类似物在妊娠妇女中临床证据有限，临床医生需充分考虑获益及潜在风险后确定是否使用。",
          "start_idx": 84,
          "end_idx": 132,
          "entities": [
            {
              "entity_id": "T563",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 11
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 132,
          "end_idx": 133,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "60",
      "paragraph": "③围手术期：围手术期需使用胰岛素控制血糖，入院前口服降糖药的患者，接受小手术的术前当晚及手术当天应停用口服降糖药，接受大中手术则应在术前3天停用口服降糖药，均改为胰岛素治疗。术前和术后可正常饮食的高血糖患者可采用基础联合餐时胰岛素方案，大中型手术术中需要静脉使用胰岛素。对于常规(非心脏)手术患者，基础联合餐时方案相比仅使用短效或速效胰岛素的方案血糖控制更佳、围手术期并发症更少。入院前已使用胰岛素者，手术日停用早餐前短效/速效胰岛素，继续使用基础胰岛素。长效胰岛素类似物在手术当日早晨予常规剂量的5 0%~100%；中效胰岛素如为晚间注射，术前1天予常规剂量的75%，手术当日早晨予常规剂量的50%~75%；预混胰岛素在手术当日早晨应更换为基础胰岛素，剂量为预混胰岛素中的中效成分的50%~75%。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "③围手术期：围手术期需使用胰岛素控制血糖，入院前口服降糖药的患者，接受小手术的术前当晚及手术当天应停用口服降糖药，接受大中手术则应在术前3天停用口服降糖药，均改为胰岛素治疗。术前和术后可正常饮食的高血糖患者可采用基础联合餐时胰岛素方案，大中型手术术中需要静脉使用胰岛素。",
          "start_idx": 0,
          "end_idx": 135,
          "entities": [
            {
              "entity_id": "T564",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 16
            },
            {
              "entity_id": "T565",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 20
            },
            {
              "entity_id": "T566",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 81,
              "end_idx": 84
            },
            {
              "entity_id": "T567",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 98,
              "end_idx": 101
            },
            {
              "entity_id": "T568",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 112,
              "end_idx": 115
            },
            {
              "entity_id": "T569",
              "entity": "静脉",
              "entity_type": "Method",
              "start_idx": 127,
              "end_idx": 129
            },
            {
              "entity_id": "T570",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 131,
              "end_idx": 134
            },
            {
              "entity_id": "T582",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 24,
              "end_idx": 26
            },
            {
              "entity_id": "T583",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 51,
              "end_idx": 53
            },
            {
              "entity_id": "T584",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 72,
              "end_idx": 74
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R187",
              "head_entity_id": "T568",
              "tail_entity_id": "T567"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R188",
              "head_entity_id": "T569",
              "tail_entity_id": "T570"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "对于常规(非心脏)手术患者，基础联合餐时方案相比仅使用短效或速效胰岛素的方案血糖控制更佳、围手术期并发症更少。",
          "start_idx": 135,
          "end_idx": 190,
          "entities": [
            {
              "entity_id": "T571",
              "entity": "速效胰岛素",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 35
            },
            {
              "entity_id": "T572",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 38,
              "end_idx": 40
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "入院前已使用胰岛素者，手术日停用早餐前短效/速效胰岛素，继续使用基础胰岛素。",
          "start_idx": 190,
          "end_idx": 228,
          "entities": [
            {
              "entity_id": "T573",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T574",
              "entity": "速效胰岛素",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 27
            },
            {
              "entity_id": "T575",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 34,
              "end_idx": 37
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "长效胰岛素类似物在手术当日早晨予常规剂量的5 0%~100%；中效胰岛素如为晚间注射，术前1天予常规剂量的75%，手术当日早晨予常规剂量的50%~75%；预混胰岛素在手术当日早晨应更换为基础胰岛素，剂量为预混胰岛素中的中效成分的50%~75%。",
          "start_idx": 228,
          "end_idx": 350,
          "entities": [
            {
              "entity_id": "T576",
              "entity": "长效胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 8
            },
            {
              "entity_id": "T577",
              "entity": "中效胰岛素",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 36
            },
            {
              "entity_id": "T578",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 40,
              "end_idx": 42
            },
            {
              "entity_id": "T579",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 77,
              "end_idx": 82
            },
            {
              "entity_id": "T580",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 95,
              "end_idx": 98
            },
            {
              "entity_id": "T581",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 102,
              "end_idx": 107
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R189",
              "head_entity_id": "T578",
              "tail_entity_id": "T577"
            }
          ]
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 350,
          "end_idx": 351,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "61",
      "paragraph": "预混胰岛素：《预混胰岛素床应用专家共识(2016年版 )》 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "预混胰岛素：《预混胰岛素床应用专家共识(2016年版 )》 ",
          "start_idx": 0,
          "end_idx": 30,
          "entities": [
            {
              "entity_id": "T585",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T586",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 12
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "62",
      "paragraph": "《中国2型糖尿病防治指南 (2013年版)》指出，每日1次基础胰岛素或每日1~2次预混胰岛素均可作为胰岛素起始治疗方案，如基础胰岛素或预混胰岛素与口服降糖药联合治疗控制血糖不达标则应将治疗方案调整为多次胰岛素注射(基础+餐时岛素或每日3次预混胰岛素类似物)。《预混胰岛素临床应用专家共识(2016年版)》是对2013年版的更新。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "《中国2型糖尿病防治指南 (2013年版)》指出，每日1次基础胰岛素或每日1~2次预混胰岛素均可作为胰岛素起始治疗方案，如基础胰岛素或预混胰岛素与口服降糖药联合治疗控制血糖不达标则应将治疗方案调整为多次胰岛素注射(基础+餐时岛素或每日3次预混胰岛素类似物)。",
          "start_idx": 0,
          "end_idx": 129,
          "entities": [
            {
              "entity_id": "T587",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 8
            },
            {
              "entity_id": "T588",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 3,
              "end_idx": 5
            },
            {
              "entity_id": "T589",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 34
            },
            {
              "entity_id": "T590",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T591",
              "entity": "每日1~2次",
              "entity_type": "Frequency",
              "start_idx": 35,
              "end_idx": 41
            },
            {
              "entity_id": "T592",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 46
            },
            {
              "entity_id": "T593",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 50,
              "end_idx": 53
            },
            {
              "entity_id": "T594",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 63,
              "end_idx": 66
            },
            {
              "entity_id": "T595",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 67,
              "end_idx": 72
            },
            {
              "entity_id": "T596",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 84,
              "end_idx": 86
            },
            {
              "entity_id": "T597",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 86,
              "end_idx": 89
            },
            {
              "entity_id": "T598",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 101,
              "end_idx": 104
            },
            {
              "entity_id": "T599",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 104,
              "end_idx": 106
            },
            {
              "entity_id": "T600",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 115,
              "end_idx": 119
            },
            {
              "entity_id": "T601",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 119,
              "end_idx": 127
            },
            {
              "entity_id": "T603",
              "entity": "岛素",
              "entity_type": "Drug",
              "start_idx": 112,
              "end_idx": 114
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R190",
              "head_entity_id": "T588",
              "tail_entity_id": "T587"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R191",
              "head_entity_id": "T590",
              "tail_entity_id": "T589"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R192",
              "head_entity_id": "T591",
              "tail_entity_id": "T592"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R193",
              "head_entity_id": "T599",
              "tail_entity_id": "T598"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R194",
              "head_entity_id": "T600",
              "tail_entity_id": "T601"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "《预混胰岛素临床应用专家共识(2016年版)》是对2013年版的更新。",
          "start_idx": 129,
          "end_idx": 164,
          "entities": [
            {
              "entity_id": "T602",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 6
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 164,
          "end_idx": 165,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "63",
      "paragraph": "作用特点 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "作用特点 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "64",
      "paragraph": "目前国内临床应用的预混胰岛素包括预混人胰岛素和预混胰岛素类似物，详见表7。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前国内临床应用的预混胰岛素包括预混人胰岛素和预混胰岛素类似物，详见表7。",
          "start_idx": 0,
          "end_idx": 37,
          "entities": [
            {
              "entity_id": "T604",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 14
            },
            {
              "entity_id": "T605",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 22
            },
            {
              "entity_id": "T606",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 31
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 37,
          "end_idx": 38,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "65",
      "paragraph": "临床用法 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床用法 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "66",
      "paragraph": "(1)适用人群 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)适用人群 ",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "67",
      "paragraph": "①每日1次方案：生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后H bA1c≥7.0%的患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①每日1次方案：生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后H bA1c≥7.0%的患者。",
          "start_idx": 0,
          "end_idx": 51,
          "entities": [
            {
              "entity_id": "T607",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 8,
              "end_idx": 14
            },
            {
              "entity_id": "T608",
              "entity": "H bA1c",
              "entity_type": "Test_items",
              "start_idx": 36,
              "end_idx": 42
            },
            {
              "entity_id": "T609",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 42,
              "end_idx": 47
            },
            {
              "entity_id": "T610",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T611",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 22,
              "end_idx": 24
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 51,
          "end_idx": 52,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "68",
      "paragraph": "②每日2次方案：新诊2型糖尿病患者，HbA1c≥9.0%同时合并明显临床症状；生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥9.0% 的患者；口服降糖药物联合基础胰岛素治疗以后，HbA1c≥7%，而空腹血糖已达标的患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②每日2次方案：新诊2型糖尿病患者，HbA1c≥9.0%同时合并明显临床症状；生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c≥9.0% 的患者；口服降糖药物联合基础胰岛素治疗以后，HbA1c≥7%，而空腹血糖已达标的患者。",
          "start_idx": 0,
          "end_idx": 121,
          "entities": [
            {
              "entity_id": "T612",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T613",
              "entity": "2型糖尿病患者",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 17
            },
            {
              "entity_id": "T614",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 10,
              "end_idx": 12
            },
            {
              "entity_id": "T615",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 23
            },
            {
              "entity_id": "T616",
              "entity": "≥9.0%",
              "entity_type": "Test_Value",
              "start_idx": 23,
              "end_idx": 28
            },
            {
              "entity_id": "T617",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 39,
              "end_idx": 45
            },
            {
              "entity_id": "T618",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 67,
              "end_idx": 72
            },
            {
              "entity_id": "T619",
              "entity": "≥9.0%",
              "entity_type": "Test_Value",
              "start_idx": 72,
              "end_idx": 77
            },
            {
              "entity_id": "T620",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 92,
              "end_idx": 95
            },
            {
              "entity_id": "T621",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 105
            },
            {
              "entity_id": "T622",
              "entity": "≥7%",
              "entity_type": "Test_Value",
              "start_idx": 105,
              "end_idx": 108
            },
            {
              "entity_id": "T623",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 110,
              "end_idx": 114
            },
            {
              "entity_id": "T624",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 53,
              "end_idx": 55
            },
            {
              "entity_id": "T625",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 82,
              "end_idx": 84
            },
            {
              "entity_id": "T626",
              "entity": "已达标",
              "entity_type": "Test_Value",
              "start_idx": 114,
              "end_idx": 117
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R195",
              "head_entity_id": "T614",
              "tail_entity_id": "T613"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R196",
              "head_entity_id": "T615",
              "tail_entity_id": "T613"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 121,
          "end_idx": 122,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "69",
      "paragraph": "③每日3次方案：预混胰岛素每日2次治疗后HbA1c≥7.0%的患者；血糖控制不达标，需要基础 +餐时胰岛素强化治疗，但不愿意接受该治疗方案的患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "③每日3次方案：预混胰岛素每日2次治疗后HbA1c≥7.0%的患者；血糖控制不达标，需要基础 +餐时胰岛素强化治疗，但不愿意接受该治疗方案的患者。",
          "start_idx": 0,
          "end_idx": 73,
          "entities": [
            {
              "entity_id": "T627",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T628",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T629",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 13,
              "end_idx": 17
            },
            {
              "entity_id": "T630",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 25
            },
            {
              "entity_id": "T631",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 25,
              "end_idx": 30
            },
            {
              "entity_id": "T632",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 34,
              "end_idx": 36
            },
            {
              "entity_id": "T633",
              "entity": "控制不达标",
              "entity_type": "Test_Value",
              "start_idx": 36,
              "end_idx": 41
            },
            {
              "entity_id": "T634",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 50,
              "end_idx": 53
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R197",
              "head_entity_id": "T629",
              "tail_entity_id": "T628"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 73,
          "end_idx": 74,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "70",
      "paragraph": "④1-2-3次方案：生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c ≥7.0%的患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "④1-2-3次方案：生活方式干预及两种或两种以上口服降糖药最大有效剂量治疗后HbA1c ≥7.0%的患者。",
          "start_idx": 0,
          "end_idx": 53,
          "entities": [
            {
              "entity_id": "T635",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 10,
              "end_idx": 16
            },
            {
              "entity_id": "T636",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 38,
              "end_idx": 43
            },
            {
              "entity_id": "T637",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 44,
              "end_idx": 49
            },
            {
              "entity_id": "T638",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 24,
              "end_idx": 26
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 53,
          "end_idx": 54,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "71",
      "paragraph": "(2)使用方法 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)使用方法 ",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "72",
      "paragraph": "①每日1次方案：起始剂量一般为0.2单位/千克体重，晚餐前注射，根据个人情况作适当调整。根据血糖监测情况调整用量，如H bA1c或空腹血糖仍不达标，可改为每日2次治疗方案。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "①每日1次方案：起始剂量一般为0.2单位/千克体重，晚餐前注射，根据个人情况作适当调整。",
          "start_idx": 0,
          "end_idx": 44,
          "entities": [
            {
              "entity_id": "T639",
              "entity": "0.2单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 15,
              "end_idx": 25
            },
            {
              "entity_id": "T640",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T641",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 29,
              "end_idx": 31
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "根据血糖监测情况调整用量，如H bA1c或空腹血糖仍不达标，可改为每日2次治疗方案。",
          "start_idx": 44,
          "end_idx": 86,
          "entities": [
            {
              "entity_id": "T642",
              "entity": "血糖监测",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 6
            },
            {
              "entity_id": "T643",
              "entity": "H bA1c",
              "entity_type": "Test_items",
              "start_idx": 14,
              "end_idx": 20
            },
            {
              "entity_id": "T644",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 21,
              "end_idx": 25
            },
            {
              "entity_id": "T645",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 26,
              "end_idx": 29
            },
            {
              "entity_id": "T646",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 33,
              "end_idx": 37
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 86,
          "end_idx": 87,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "73",
      "paragraph": "②每日2次方案：对于新诊患者或预混胰岛素起始的患者，一般起始用量为0.2~0.4单位/千克体重或10~12单位/天，按1：1分配到早餐前和晚餐前；对于基础胰岛素联合口服药方案转预混胰岛素方案者，一般以基础胰岛素与预混胰岛素以1：1.3的比例进行剂量转换，按1：1分配到早餐前和晚餐前。临床医生应对根据患者具体情况决定预混胰岛素类别、日总剂量和早晚餐前剂量的分配比例。不建议同时使用胰岛素促泌剂，但可继续使用二甲双胍或α-糖苷酶抑制剂，需视患者个体情况决定是否停用噻唑烷二酮类药物。中预混胰岛素(赖朋胰岛素50、门冬胰岛素50)主要针对餐后血糖升高明显或者血糖波动较大的患者(如口服降糖药失效后，早餐后血糖≥13.5毫摩尔/升或早餐前后血糖波动≥4.4毫摩尔/升，以及饮食中碳水化合物比例较高的患者；若低预混人胰岛素每日2次治疗的患者餐后血糖≥11.1毫摩尔/升，临床医生可依据具体情况考虑等剂量改为低预混胰岛素类似物(赖脯胰岛素7 5/25、门冬胰岛素30)或中预混胰岛素类似物。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "②每日2次方案：对于新诊患者或预混胰岛素起始的患者，一般起始用量为0.2~0.4单位/千克体重或10~12单位/天，按1：1分配到早餐前和晚餐前；对于基础胰岛素联合口服药方案转预混胰岛素方案者，一般以基础胰岛素与预混胰岛素以1：1.3的比例进行剂量转换，按1：1分配到早餐前和晚餐前。",
          "start_idx": 0,
          "end_idx": 142,
          "entities": [
            {
              "entity_id": "T647",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T648",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 20
            },
            {
              "entity_id": "T649",
              "entity": "0.2~0.4单位/千克体重",
              "entity_type": "Amount",
              "start_idx": 33,
              "end_idx": 47
            },
            {
              "entity_id": "T650",
              "entity": "10~12单位/天",
              "entity_type": "Amount",
              "start_idx": 48,
              "end_idx": 57
            },
            {
              "entity_id": "T651",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 77,
              "end_idx": 80
            },
            {
              "entity_id": "T652",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 88,
              "end_idx": 93
            },
            {
              "entity_id": "T653",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 102,
              "end_idx": 105
            },
            {
              "entity_id": "T654",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 106,
              "end_idx": 111
            },
            {
              "entity_id": "T680",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 82,
              "end_idx": 84
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R198",
              "head_entity_id": "T647",
              "tail_entity_id": "T648"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R199",
              "head_entity_id": "T649",
              "tail_entity_id": "T648"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R200",
              "head_entity_id": "T650",
              "tail_entity_id": "T648"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "临床医生应对根据患者具体情况决定预混胰岛素类别、日总剂量和早晚餐前剂量的分配比例。",
          "start_idx": 142,
          "end_idx": 183,
          "entities": [
            {
              "entity_id": "T655",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 21
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "不建议同时使用胰岛素促泌剂，但可继续使用二甲双胍或α-糖苷酶抑制剂，需视患者个体情况决定是否停用噻唑烷二酮类药物。",
          "start_idx": 183,
          "end_idx": 240,
          "entities": [
            {
              "entity_id": "T656",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 13
            },
            {
              "entity_id": "T657",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 24
            },
            {
              "entity_id": "T658",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 33
            },
            {
              "entity_id": "T659",
              "entity": "噻唑烷二酮类药物",
              "entity_type": "Drug",
              "start_idx": 48,
              "end_idx": 56
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "中预混胰岛素(赖朋胰岛素50、门冬胰岛素50)主要针对餐后血糖升高明显或者血糖波动较大的患者(如口服降糖药失效后，早餐后血糖≥13.5毫摩尔/升或早餐前后血糖波动≥4.4毫摩尔/升，以及饮食中碳水化合物比例较高的患者；若低预混人胰岛素每日2次治疗的患者餐后血糖≥11.1毫摩尔/升，临床医生可依据具体情况考虑等剂量改为低预混胰岛素类似物(赖脯胰岛素7 5/25、门冬胰岛素30)或中预混胰岛素类似物。",
          "start_idx": 240,
          "end_idx": 440,
          "entities": [
            {
              "entity_id": "T660",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 6
            },
            {
              "entity_id": "T661",
              "entity": "赖朋胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 12
            },
            {
              "entity_id": "T662",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 20
            },
            {
              "entity_id": "T663",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T664",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 37,
              "end_idx": 39
            },
            {
              "entity_id": "T665",
              "entity": "升高明显",
              "entity_type": "Test_Value",
              "start_idx": 31,
              "end_idx": 35
            },
            {
              "entity_id": "T666",
              "entity": "波动较大",
              "entity_type": "Test_Value",
              "start_idx": 39,
              "end_idx": 43
            },
            {
              "entity_id": "T667",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 60,
              "end_idx": 62
            },
            {
              "entity_id": "T668",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 77,
              "end_idx": 79
            },
            {
              "entity_id": "T669",
              "entity": "≥13.5毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 62,
              "end_idx": 72
            },
            {
              "entity_id": "T670",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 79,
              "end_idx": 81
            },
            {
              "entity_id": "T671",
              "entity": "≥4.4毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 81,
              "end_idx": 90
            },
            {
              "entity_id": "T672",
              "entity": "预混人胰岛素",
              "entity_type": "Drug",
              "start_idx": 111,
              "end_idx": 117
            },
            {
              "entity_id": "T673",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 117,
              "end_idx": 121
            },
            {
              "entity_id": "T674",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 126,
              "end_idx": 130
            },
            {
              "entity_id": "T675",
              "entity": "≥11.1毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 130,
              "end_idx": 140
            },
            {
              "entity_id": "T676",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 160,
              "end_idx": 168
            },
            {
              "entity_id": "T677",
              "entity": "赖脯胰岛素",
              "entity_type": "Drug",
              "start_idx": 169,
              "end_idx": 174
            },
            {
              "entity_id": "T678",
              "entity": "门冬胰岛素",
              "entity_type": "Drug",
              "start_idx": 181,
              "end_idx": 186
            },
            {
              "entity_id": "T679",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 191,
              "end_idx": 199
            },
            {
              "entity_id": "T681",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 48,
              "end_idx": 50
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R201",
              "head_entity_id": "T673",
              "tail_entity_id": "T672"
            }
          ]
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 440,
          "end_idx": 441,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "75",
      "paragraph": "④1-2-3次方案：使用预混胰岛素类似物，餐后血糖升高明显者选择中预混制剂。每日1次起始剂量一般为10~12单位，晚餐前注射，根据早餐前血糖调整剂量；如HbA1c或餐前血糖不达标，则早餐前增加3~6单位，根据晚餐前和空腹血糖调整早餐前和晚餐前剂量；如HbA1c或午餐后血糖仍不达标，则午餐前加用3位或将早餐前剂量按1：1分配到早、午餐前，根据午餐后或晚餐血糖调整午餐前剂量。预混胰岛素类做物每日1次治疗时可根据具体情况调整口服降糖药；当调整为每日2次或3次时，不建议同时使用胰岛素促泌剂，可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用噻唑烷二酮类药物。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "④1-2-3次方案：使用预混胰岛素类似物，餐后血糖升高明显者选择中预混制剂。每日1次起始剂量一般为10~12单位，晚餐前注射，根据早餐前血糖调整剂量；如HbA1c或餐前血糖不达标，则早餐前增加3~6单位，根据晚餐前和空腹血糖调整早餐前和晚餐前剂量；如HbA1c或午餐后血糖仍不达标，则午餐前加用3位或将早餐前剂量按1：1分配到早、午餐前，根据午餐后或晚餐血糖调整午餐前剂量。预混胰岛素类做物每日1次治疗时可根据具体情况调整口服降糖药；当调整为每日2次或3次时，不建议同时使用胰岛素促泌剂，可继续使用二甲双胍或α-糖苷酶抑制剂，视患者个体情况决定是否停用噻唑烷二酮类药物。",
          "start_idx": 0,
          "end_idx": 285,
          "entities": [
            {
              "entity_id": "T682",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 20
            },
            {
              "entity_id": "T683",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 21,
              "end_idx": 25
            },
            {
              "entity_id": "T684",
              "entity": "升高明显",
              "entity_type": "Test_Value",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T685",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 38,
              "end_idx": 42
            },
            {
              "entity_id": "T686",
              "entity": "10~12单位",
              "entity_type": "Amount",
              "start_idx": 49,
              "end_idx": 56
            },
            {
              "entity_id": "T687",
              "entity": "注射",
              "entity_type": "Method",
              "start_idx": 60,
              "end_idx": 62
            },
            {
              "entity_id": "T688",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 68,
              "end_idx": 70
            },
            {
              "entity_id": "T689",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 76,
              "end_idx": 81
            },
            {
              "entity_id": "T690",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 82,
              "end_idx": 86
            },
            {
              "entity_id": "T691",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 86,
              "end_idx": 89
            },
            {
              "entity_id": "T692",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 108,
              "end_idx": 112
            },
            {
              "entity_id": "T693",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 125,
              "end_idx": 130
            },
            {
              "entity_id": "T694",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 132,
              "end_idx": 136
            },
            {
              "entity_id": "T695",
              "entity": "不达标",
              "entity_type": "Test_Value",
              "start_idx": 137,
              "end_idx": 140
            },
            {
              "entity_id": "T696",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 177,
              "end_idx": 179
            },
            {
              "entity_id": "T697",
              "entity": "每日2次或3次",
              "entity_type": "Frequency",
              "start_idx": 221,
              "end_idx": 228
            },
            {
              "entity_id": "T698",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 237,
              "end_idx": 243
            },
            {
              "entity_id": "T699",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 249,
              "end_idx": 253
            },
            {
              "entity_id": "T700",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 254,
              "end_idx": 262
            },
            {
              "entity_id": "T701",
              "entity": "噻唑烷二酮类药物",
              "entity_type": "Drug",
              "start_idx": 276,
              "end_idx": 284
            },
            {
              "entity_id": "T702",
              "entity": "每日1次",
              "entity_type": "Frequency",
              "start_idx": 195,
              "end_idx": 199
            },
            {
              "entity_id": "T703",
              "entity": "预混胰岛素类做物",
              "entity_type": "Drug",
              "start_idx": 187,
              "end_idx": 195
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R202",
              "head_entity_id": "T702",
              "tail_entity_id": "T703"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 285,
          "end_idx": 286,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "74",
      "paragraph": "③每日3次方案：建议使用预混胰岛素类似物。当预混胰岛素每日2次转为3次时，早晚餐前可等剂量转换，午餐前加2-4单位或每天胰岛素总量的10%，并可能需要减少早餐前的剂量2~4单位；当替代基础+餐时方案进行强化治疗时，医生需要根据具体情况制定方案。若低预混胰岛素每2次治疗，HbA1c≥7.0%，早餐后血糖<10.0毫摩尔/升，可考虑调整为低预混胰岛素类似物每日3次；若早餐后血糖≥10.0毫摩尔/升，则可考虑调整为中预混胰岛素类似物每日3次治疗；中预混胰岛素类物每日3次治疗者，如餐后血糖控制好而空腹血糖>6毫摩尔/升，可考虑将晚餐前调整为低预混胰岛素类似物。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "③每日3次方案：建议使用预混胰岛素类似物。当预混胰岛素每日2次转为3次时，早晚餐前可等剂量转换，午餐前加2-4单位或每天胰岛素总量的10%，并可能需要减少早餐前的剂量2~4单位；当替代基础+餐时方案进行强化治疗时，医生需要根据具体情况制定方案。",
          "start_idx": 0,
          "end_idx": 122,
          "entities": [
            {
              "entity_id": "T704",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 20
            },
            {
              "entity_id": "T705",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T706",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 27
            },
            {
              "entity_id": "T707",
              "entity": "每日2次",
              "entity_type": "Frequency",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T708",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 60,
              "end_idx": 63
            },
            {
              "entity_id": "T726",
              "entity": "2-4单位",
              "entity_type": "Amount",
              "start_idx": 52,
              "end_idx": 57
            },
            {
              "entity_id": "T727",
              "entity": "2~4单位",
              "entity_type": "Amount",
              "start_idx": 83,
              "end_idx": 88
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R203",
              "head_entity_id": "T705",
              "tail_entity_id": "T704"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R204",
              "head_entity_id": "T707",
              "tail_entity_id": "T706"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R205",
              "head_entity_id": "T726",
              "tail_entity_id": "T708"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R206",
              "head_entity_id": "T727",
              "tail_entity_id": "T708"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "若低预混胰岛素每2次治疗，HbA1c≥7.0%，早餐后血糖<10.0毫摩尔/升，可考虑调整为低预混胰岛素类似物每日3次；若早餐后血糖≥10.0毫摩尔/升，则可考虑调整为中预混胰岛素类似物每日3次治疗；中预混胰岛素类物每日3次治疗者，如餐后血糖控制好而空腹血糖>6毫摩尔/升，可考虑将晚餐前调整为低预混胰岛素类似物。",
          "start_idx": 122,
          "end_idx": 279,
          "entities": [
            {
              "entity_id": "T709",
              "entity": "预混胰岛素",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 7
            },
            {
              "entity_id": "T710",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 18
            },
            {
              "entity_id": "T711",
              "entity": "≥7.0%",
              "entity_type": "Test_Value",
              "start_idx": 18,
              "end_idx": 23
            },
            {
              "entity_id": "T712",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 25,
              "end_idx": 29
            },
            {
              "entity_id": "T713",
              "entity": "<10.0毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 29,
              "end_idx": 39
            },
            {
              "entity_id": "T714",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 47,
              "end_idx": 55
            },
            {
              "entity_id": "T715",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 55,
              "end_idx": 59
            },
            {
              "entity_id": "T716",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 62,
              "end_idx": 66
            },
            {
              "entity_id": "T717",
              "entity": "≥10.0毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 66,
              "end_idx": 76
            },
            {
              "entity_id": "T718",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 85,
              "end_idx": 93
            },
            {
              "entity_id": "T719",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 93,
              "end_idx": 97
            },
            {
              "entity_id": "T720",
              "entity": "预混胰岛素类物",
              "entity_type": "Drug",
              "start_idx": 101,
              "end_idx": 108
            },
            {
              "entity_id": "T721",
              "entity": "每日3次",
              "entity_type": "Frequency",
              "start_idx": 108,
              "end_idx": 112
            },
            {
              "entity_id": "T722",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 117,
              "end_idx": 121
            },
            {
              "entity_id": "T723",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 125,
              "end_idx": 129
            },
            {
              "entity_id": "T724",
              "entity": ">6毫摩尔/升",
              "entity_type": "Test_Value",
              "start_idx": 129,
              "end_idx": 136
            },
            {
              "entity_id": "T725",
              "entity": "预混胰岛素类似物",
              "entity_type": "Drug",
              "start_idx": 148,
              "end_idx": 156
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R207",
              "head_entity_id": "T715",
              "tail_entity_id": "T714"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R208",
              "head_entity_id": "T719",
              "tail_entity_id": "T718"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R209",
              "head_entity_id": "T721",
              "tail_entity_id": "T720"
            }
          ]
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 279,
          "end_idx": 280,
          "entities": [],
          "relations": []
        }
      ]
    }
  ]
}